Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
54000,,3548246,CHEMBL1282945,Antibacterial activity against cefotaxime-intermediate Streptococcus pneumoniae assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,970279,=,1,0,=,Activity,%,97.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,97.2
54001,,3548252,CHEMBL1282938,Antibacterial activity against penicillin-nonsusceptible Streptococcus pneumoniae isolate by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970279,<=,1,1,<=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54002,,3548253,CHEMBL1282938,Antibacterial activity against penicillin-nonsusceptible Streptococcus pneumoniae isolate by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970279,<=,1,1,<=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54003,,3548254,CHEMBL1282940,Antibacterial activity against amoxicillin-intermediate Streptococcus pneumoniae isolate by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970279,<=,1,1,<=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54004,,3548255,CHEMBL1282944,Antibacterial activity against cefotaxime-intermediate Streptococcus pneumoniae isolate by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970279,<=,1,1,<=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54005,,3548256,CHEMBL1283698,Antibacterial activity against cefotaxime-resistant Streptococcus pneumoniae isolate by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970279,<=,1,1,<=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54006,,3548257,CHEMBL1283700,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970279,<=,1,1,<=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54007,,3548259,CHEMBL1282942,Antibacterial activity against amoxicillin-resistant Streptococcus pneumoniae isolate by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970279,<,1,1,<,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54008,,3548276,CHEMBL1283828,Antibacterial activity against levofloxacin-resistant Streptococcus pneumoniae isolate by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970279,>=,1,1,>=,MIC90,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,32.0
54009,,3551880,CHEMBL1284664,Inhibition of DNA supercoiling activity of wild type Mycobacterium tuberculosis DNA gyrase A,B,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275259,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,970539,=,1,1,=,IC50,nM,52000.0,CHEMBL4165,Mycobacterium tuberculosis,DNA gyrase subunit A,1773.0,,IC50,uM,UO_0000065,52.0
54010,,3551881,CHEMBL1284665,Inhibition of DNA supercoiling activitysof Mycobacterium tuberculosis DNA gyrase subunit A A90V mutant,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275259,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,970539,>,1,1,>,IC50,nM,300000.0,CHEMBL4165,Mycobacterium tuberculosis,DNA gyrase subunit A,1773.0,,IC50,uM,UO_0000065,300.0
54011,,3551882,CHEMBL1284666,Inhibition of DNA supercoiling activity of Mycobacterium tuberculosis DNA gyrase subunit A D94G mutant,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275259,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,970539,>,1,1,>,IC50,nM,300000.0,CHEMBL4165,Mycobacterium tuberculosis,DNA gyrase subunit A,1773.0,,IC50,uM,UO_0000065,300.0
54012,,3553347,CHEMBL1281963,Antibacterial activity against coagulase-negative Staphylococcus hominis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC50,ug ml-1,UO_0000274,0.12
54013,,3553354,CHEMBL1281962,Antibacterial activity against coagulase-negative Staphylococcus lugdunensis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC50,ug ml-1,UO_0000274,0.12
54014,,3553361,CHEMBL1281961,Antibacterial activity against coagulase-negative Staphylococcus haemolyticus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,0.12
54015,,3553368,CHEMBL1281960,Antibacterial activity against coagulase-negative Staphylococcus epidermidis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.12
54016,,3553375,CHEMBL1281959,Antibacterial activity against methicillin susceptible Staphylococcus aureus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.12
54017,,3553382,CHEMBL1281958,Antibacterial activity against methicillin resistant Staphylococcus aureus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
54018,,3553389,CHEMBL1281957,Antibacterial activity against Staphylococcus aureus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.12
54019,,3553396,CHEMBL1281970,"Antibacterial activity against methicillin-susceptible, coagulase-negative Staphylococcus obtained from complicated skin and skin structure infections by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.06
54020,,3553403,CHEMBL1281969,"Antibacterial activity against methicillin-resistant, oxacillin-susceptible, coagulase-negative, mecA-positive Staphylococcus lugdunensis obtained from complicated skin and skin structure infections by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC,ug ml-1,UO_0000274,0.06
54021,,3553410,CHEMBL1281968,Antibacterial activity against coagulase-negative Staphylococcus warneri obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC,ug ml-1,UO_0000274,0.06
54022,,3553417,CHEMBL1281967,Antibacterial activity against coagulase-negative Staphylococcus sciuri obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC,ug ml-1,UO_0000274,0.06
54023,,3553424,CHEMBL1281966,Antibacterial activity against coagulase-negative Staphylococcus cohnii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,MIC,ug ml-1,UO_0000274,0.06
54024,,3553431,CHEMBL1281965,Antibacterial activity against coagulase-negative Staphylococcus saprophyticus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,0.06
54025,,3553438,CHEMBL1281964,Antibacterial activity against coagulase-negative Staphylococcus capitis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC,ug ml-1,UO_0000274,0.06
54026,,3553445,CHEMBL1281963,Antibacterial activity against coagulase-negative Staphylococcus hominis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,0.06
54027,,3553452,CHEMBL1281962,Antibacterial activity against coagulase-negative Staphylococcus lugdunensis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC,ug ml-1,UO_0000274,0.06
54028,,3553459,CHEMBL1281961,Antibacterial activity against coagulase-negative Staphylococcus haemolyticus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.06
54029,,3553466,CHEMBL1281960,Antibacterial activity against coagulase-negative Staphylococcus epidermidis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
54030,,3553473,CHEMBL1281959,Antibacterial activity against methicillin susceptible Staphylococcus aureus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
54031,,3553480,CHEMBL1281958,Antibacterial activity against methicillin resistant Staphylococcus aureus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
54032,,3553487,CHEMBL1281957,Antibacterial activity against Staphylococcus aureus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
54033,,3553494,CHEMBL1279989,Antibacterial activity against Acinetobacter baumannii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,4.0
54034,,3553502,CHEMBL1279990,Antibacterial activity against Pseudomonas fluorescens obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,MIC50,ug ml-1,UO_0000274,4.0
54035,,3553510,CHEMBL1279991,Antibacterial activity against Stenotrophomonas maltophilia obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC50,ug ml-1,UO_0000274,4.0
54036,,3553518,CHEMBL1279995,Antibacterial activity against Enterobacter aerogenes obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC50,ug ml-1,UO_0000274,0.06
54037,,3553526,CHEMBL1279996,Antibacterial activity against Klebsiella oxytoca obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC50,ug ml-1,UO_0000274,0.06
54038,,3553534,CHEMBL1282106,Antibacterial activity against Citrobacter braakii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,8.0
54039,,3553542,CHEMBL1282107,Antibacterial activity against Citrobacter freundii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,8.0
54040,,3553550,CHEMBL1282108,Antibacterial activity against Enterobacter amnigenus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,8.0
54041,,3553558,CHEMBL1282109,Antibacterial activity against Enterobacter cloacae obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,4.0
54042,,3553566,CHEMBL1282110,Antibacterial activity against Escherichia coli obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,1.0
54043,,3553574,CHEMBL1282111,Antibacterial activity against Klebsiella pneumoniae obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,4.0
54044,,3553582,CHEMBL1282112,Antibacterial activity against Morganella morganii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,64.0
54045,,3553590,CHEMBL1282113,Antibacterial activity against Proteus mirabilis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,8.0
54046,,3553598,CHEMBL1282114,Antibacterial activity against Proteus penneri obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,8.0
54047,,3553606,CHEMBL1282115,Antibacterial activity against Proteus vulgaris obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC90,ug ml-1,UO_0000274,8.0
54048,,3553614,CHEMBL1282116,Antibacterial activity against Providencia stuartii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC90,ug ml-1,UO_0000274,8.0
54049,,3553622,CHEMBL1282117,Antibacterial activity against Salmonella spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614446,Salmonella,Salmonella,590.0,,MIC90,ug ml-1,UO_0000274,8.0
54050,,3553630,CHEMBL1282118,Antibacterial activity against Serratia marcescens obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,8.0
54051,,3553638,CHEMBL1279989,Antibacterial activity against Acinetobacter baumannii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,8.0
54052,,3553646,CHEMBL1279990,Antibacterial activity against Pseudomonas fluorescens obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,MIC90,ug ml-1,UO_0000274,8.0
54053,,3553654,CHEMBL1279991,Antibacterial activity against Stenotrophomonas maltophilia obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,8.0
54054,,3553662,CHEMBL1279995,Antibacterial activity against Enterobacter aerogenes obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,8.0
54055,,3553670,CHEMBL1279996,Antibacterial activity against Klebsiella oxytoca obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC90,ug ml-1,UO_0000274,8.0
54056,,3564588,CHEMBL1282102,Antibacterial activity against Gemella morbillorum obtained from complicated skin and skin structure infections by RapID ANA system,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54057,,3564597,CHEMBL1281981,Antibacterial activity against Bacillus spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL612428,Bacillus,Bacillus,1386.0,,MIC,ug ml-1,UO_0000274,0.06
54058,,3564606,CHEMBL1281980,Antibacterial activity against Aerococcus viridans obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54059,,3564615,CHEMBL1281979,Antibacterial activity against Staphylococcus intermedius obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614422,Staphylococcus intermedius,Staphylococcus intermedius,1285.0,,MIC,ug ml-1,UO_0000274,0.03
54060,,3564624,CHEMBL1281978,Antibacterial activity against Streptococcus mitis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.03
54061,,3564636,CHEMBL1281977,Antibacterial activity against Streptococcus constellatus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC,ug ml-1,UO_0000274,0.25
54062,,3564644,CHEMBL1281972,Antibacterial activity against Enterococcus faecium obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,4.0
54063,,3564651,CHEMBL1281972,Antibacterial activity against Enterococcus faecium obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,1.0
54064,,3564700,CHEMBL1281976,Antibacterial activity against Streptococcus sp. 'group G' obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
54065,,3564701,CHEMBL1281975,Antibacterial activity against Streptococcus sp. 'group C' obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
54066,,3564702,CHEMBL1281974,Antibacterial activity against Streptococcus pyogenes obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.5
54067,,3564703,CHEMBL1281973,Antibacterial activity against Streptococcus agalactiae obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
54068,,3564704,CHEMBL1281971,Antibacterial activity against Enterococcus faecalis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,2.0
54069,,3564705,CHEMBL1281976,Antibacterial activity against Streptococcus sp. 'group G' obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
54070,,3564706,CHEMBL1281975,Antibacterial activity against Streptococcus sp. 'group C' obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
54071,,3564707,CHEMBL1281974,Antibacterial activity against Streptococcus pyogenes obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
54072,,3564708,CHEMBL1281973,Antibacterial activity against Streptococcus agalactiae obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.5
54073,,3564709,CHEMBL1281971,Antibacterial activity against Enterococcus faecalis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
54074,,3564710,CHEMBL1281976,Antibacterial activity against Streptococcus sp. 'group G' obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
54075,,3564711,CHEMBL1281975,Antibacterial activity against Streptococcus sp. 'group C' obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54076,,3564712,CHEMBL1281974,Antibacterial activity against Streptococcus pyogenes obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
54077,,3564713,CHEMBL1281973,Antibacterial activity against Streptococcus agalactiae obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
54078,,3564714,CHEMBL1281971,Antibacterial activity against Enterococcus faecalis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
54079,,3564778,CHEMBL1281970,"Antibacterial activity against methicillin-susceptible, coagulase-negative Staphylococcus obtained from complicated skin and skin structure infections by agar dilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,0.25
54080,,3564785,CHEMBL1281969,"Antibacterial activity against methicillin-resistant, oxacillin-susceptible, coagulase-negative, mecA-positive Staphylococcus lugdunensis obtained from complicated skin and skin structure infections by agar dilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC90,ug ml-1,UO_0000274,8.0
54081,,3564792,CHEMBL1281968,Antibacterial activity against coagulase-negative Staphylococcus warneri obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC90,ug ml-1,UO_0000274,8.0
54082,,3564799,CHEMBL1281967,Antibacterial activity against coagulase-negative Staphylococcus sciuri obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC90,ug ml-1,UO_0000274,8.0
54083,,3564806,CHEMBL1281966,Antibacterial activity against coagulase-negative Staphylococcus cohnii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,MIC90,ug ml-1,UO_0000274,8.0
54084,,3564813,CHEMBL1281965,Antibacterial activity against coagulase-negative Staphylococcus saprophyticus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC90,ug ml-1,UO_0000274,8.0
54085,,3564820,CHEMBL1281964,Antibacterial activity against coagulase-negative Staphylococcus capitis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC90,ug ml-1,UO_0000274,8.0
54086,,3564827,CHEMBL1281963,Antibacterial activity against coagulase-negative Staphylococcus hominis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC90,ug ml-1,UO_0000274,8.0
54087,,3564834,CHEMBL1281962,Antibacterial activity against coagulase-negative Staphylococcus lugdunensis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC90,ug ml-1,UO_0000274,8.0
54088,,3564841,CHEMBL1281961,Antibacterial activity against coagulase-negative Staphylococcus haemolyticus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,8.0
54089,,3564848,CHEMBL1281960,Antibacterial activity against coagulase-negative Staphylococcus epidermidis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,8.0
54090,,3564855,CHEMBL1281959,Antibacterial activity against methicillin susceptible Staphylococcus aureus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
54091,,3564862,CHEMBL1281958,Antibacterial activity against methicillin resistant Staphylococcus aureus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
54092,,3564869,CHEMBL1281957,Antibacterial activity against Staphylococcus aureus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,4.0
54093,,3564876,CHEMBL1281970,"Antibacterial activity against methicillin-susceptible, coagulase-negative Staphylococcus obtained from complicated skin and skin structure infections by agar dilution method",F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.12
54094,,3564883,CHEMBL1281969,"Antibacterial activity against methicillin-resistant, oxacillin-susceptible, coagulase-negative, mecA-positive Staphylococcus lugdunensis obtained from complicated skin and skin structure infections by agar dilution method",F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC50,ug ml-1,UO_0000274,0.25
54095,,3564890,CHEMBL1281968,Antibacterial activity against coagulase-negative Staphylococcus warneri obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC50,ug ml-1,UO_0000274,0.12
54096,,3564897,CHEMBL1281967,Antibacterial activity against coagulase-negative Staphylococcus sciuri obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC50,ug ml-1,UO_0000274,0.12
54097,,3564904,CHEMBL1281966,Antibacterial activity against coagulase-negative Staphylococcus cohnii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,MIC50,ug ml-1,UO_0000274,0.12
54098,,3564911,CHEMBL1281965,Antibacterial activity against coagulase-negative Staphylococcus saprophyticus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC50,ug ml-1,UO_0000274,0.12
54099,,3564918,CHEMBL1281964,Antibacterial activity against coagulase-negative Staphylococcus capitis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC50,ug ml-1,UO_0000274,0.12
54100,,3566365,CHEMBL1279831,"Antimicrobial activity against Mycobacterium tuberculosis infected in patient at 1000 mg/day, po administered for 7 days by HPLC",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275405,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969602,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
54101,,3566366,CHEMBL1279832,"Ratio of fAUC in tuberculosis patient at 1000 mg/day, po administered for 7 days to MIC for Mycobacterium tuberculosis",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275405,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969602,=,1,0,=,RatioAUC/MIC,,187.67,CHEMBL612545,,Unchecked,,,RatioAUC/MIC,,,187.67
54102,,3566941,CHEMBL1279248,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
54103,,3566942,CHEMBL1279247,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
54104,,3567007,CHEMBL1279250,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,1.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,1.7
54105,,3567012,CHEMBL1279246,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,2.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,2.1
54106,,3567029,CHEMBL1278287,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,6.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,6.9
54107,,3567030,CHEMBL1278284,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,6.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,6.9
54108,,3567032,CHEMBL1278285,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,7.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,7.1
54109,,3567034,CHEMBL1278288,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,7.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,7.3
54110,,3567053,CHEMBL1278286,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,20.0
54111,,3567062,CHEMBL1279493,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,42.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,42.9
54112,,3567065,CHEMBL1279242,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,45.8,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,45.8
54113,,3567067,CHEMBL1279241,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,46.7,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,46.7
54114,,3567070,CHEMBL1279244,Antimicrobial activity against vancomycin-resistant Enterococcus sp. assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,51.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,51.0
54115,,3567071,CHEMBL1279243,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,52.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,52.0
54116,,3567072,CHEMBL1279494,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,52.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,52.3
54117,,3567077,CHEMBL1279245,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,56.8,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,56.8
54118,,3567082,CHEMBL1279256,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,66.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,66.7
54119,,3567094,CHEMBL1279492,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,80.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,80.0
54120,,3567105,CHEMBL1278279,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,91.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,91.5
54121,,3567109,CHEMBL1278283,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,91.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,91.8
54122,,3567110,CHEMBL1278282,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,91.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,91.8
54123,,3567113,CHEMBL1278280,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,92.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,92.6
54124,,3567160,CHEMBL1278281,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
54125,,3567161,CHEMBL1279255,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
54126,,3567162,CHEMBL1279254,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
54127,,3567163,CHEMBL1279253,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
54128,,3567164,CHEMBL1279252,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
54129,,3567165,CHEMBL1279251,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
54130,,3567237,CHEMBL1278294,Antimicrobial activity against Haemophilus influenzae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,0.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,0.0
54131,,3567239,CHEMBL1278293,Antimicrobial activity against Haemophilus influenzae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,0.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,0.0
54132,,3567241,CHEMBL1278291,Antimicrobial activity against Haemophilus influenzae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,0.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,0.0
54133,,3567243,CHEMBL1278290,Antimicrobial activity against Haemophilus influenzae assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,0.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,0.0
54134,,3567245,CHEMBL1278289,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,0.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,0.0
54135,,3567247,CHEMBL1279228,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,0.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,0.0
54136,,3567668,CHEMBL1279225,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,1.8,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,1.8
54137,,3567669,CHEMBL1279226,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,3.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,3.3
54138,,3567670,CHEMBL1279230,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,3.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,3.6
54139,,3567672,CHEMBL1279229,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,3.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,3.9
54140,,3567676,CHEMBL1279185,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,4.2,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,4.2
54141,,3567679,CHEMBL1279183,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,5.9,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,5.9
54142,,3567682,CHEMBL1279184,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,6.3,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,6.3
54143,,3567694,CHEMBL1279227,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,11.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,11.5
54144,,3567702,CHEMBL1279238,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,19.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,19.8
54145,,3567706,CHEMBL1279240,Antimicrobial activity against CTX-M ESBL producing Escherichia coli assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,21.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,21.1
54146,,3567708,CHEMBL1279236,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,21.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,21.3
54147,,3567709,CHEMBL1279231,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,21.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,21.5
54148,,3567712,CHEMBL1279239,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,23.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,23.3
54149,,3567715,CHEMBL1279237,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,24.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,24.1
54150,,3567717,CHEMBL1279234,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,24.2,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,24.2
54151,,3567718,CHEMBL1279235,Antimicrobial activity against ESBL producing Klebsiella pneumoniae assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,25.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,25.5
54152,,3567721,CHEMBL1279232,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,35.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,35.9
54153,,3567723,CHEMBL1279233,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969537,=,1,0,=,Activity,%,40.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,40.0
54154,,3567980,CHEMBL1278696,Antibacterial activity against ESBL-producing Escherichia coli isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969546,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
54155,,3567983,CHEMBL1278694,Antibacterial activity against AmpC-producing Escherichia coli isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969546,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
54156,,3567985,CHEMBL1278695,Antibacterial activity against ESBL-producing Escherichia coli assessed as sensitive isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969546,=,1,0,=,Activity,%,16.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,16.7
54157,,3567988,CHEMBL1278699,Antibacterial activity against AmpC-producing Escherichia coli assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969546,=,1,0,=,Activity,%,26.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,26.6
54158,,3568070,CHEMBL1278557,Antimicrobial activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6763 expressing gyrA Ser84Leu/Ser85Pro and grlA Ser80Phe/Glu84Lys mutants by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969660,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
54159,,3568071,CHEMBL1278558,"Antimicrobial activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6764 expressing gyrA Ser84Leu, gyrB Asp437Glu norA T389C and grlA Ser80Phe/Glu84Lys mutants by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969660,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
54160,,3568072,CHEMBL1278559,"Antimicrobial activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6765 expressing gyrA Ser84Leu, norA T389C and grlA Ser80Phe/Glu84Lys mutants by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969660,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
54161,,3568073,CHEMBL1278560,Antimicrobial activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6766 expressing gyrA Glu84Lys and grlA Ser80Phe mutants by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969660,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
54162,,3568074,CHEMBL1278561,Antimicrobial activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6767 expressing gyrA Glu84Lys and grlA Ser80Phe mutants by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969660,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
54163,,3568075,CHEMBL1278562,Antimicrobial activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6768 expressing gyrA Glu84Lys and grlA Ser80Phe mutants by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969660,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
54164,,3568076,CHEMBL1278563,Antimicrobial activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus JCSC 6769 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969660,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
54165,,3568077,CHEMBL1278564,Antimicrobial activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus JCSC 6770 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969660,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54166,,3568078,CHEMBL1278565,Antimicrobial activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus JCSC 6822 harboring mutation in norA gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969660,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54167,Not Active,3568094,CHEMBL1278566,Bactericidal activity against methicillin-resistant Staphylococcus aureus at 4 times MIC upto 60 mins by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54168,Not Active,3568095,CHEMBL1278567,Bactericidal activity against methicillin-resistant Staphylococcus aureus at 8 times MIC upto 60 mins by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54169,Not Active,3568096,CHEMBL1278568,Bactericidal activity against methicillin-resistant Staphylococcus aureus at 16 times MIC upto 60 mins by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54170,Active,3568097,CHEMBL1278572,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 4 times MIC after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54171,Active,3568098,CHEMBL1278573,Bactericidal activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus at 4 times MIC after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54172,Active,3568099,CHEMBL1278574,Bactericidal activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus at 4 times MIC after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54173,Active,3568100,CHEMBL1278575,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 8 times MIC after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54174,Active,3568101,CHEMBL1278576,Bactericidal activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus at 8 times MIC after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54175,Active,3568102,CHEMBL1278577,Bactericidal activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus at 8 times MIC after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54176,Active,3568103,CHEMBL1278611,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 16 times MIC after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54177,Active,3568104,CHEMBL1278612,Bactericidal activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus at 16 times MIC after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54178,Active,3568105,CHEMBL1278613,Bactericidal activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus at 16 times MIC after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54179,Active,3568106,CHEMBL1278614,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 2048 ug/ml after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54180,Active,3568107,CHEMBL1278615,Bactericidal activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus at 2048 ug/ml after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54181,Active,3568108,CHEMBL1278616,Bactericidal activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus at 2048 ug/ml after 24 hrs by time-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969660,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
54182,,3568339,CHEMBL1278696,Antibacterial activity against ESBL-producing Escherichia coli isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969546,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
54183,,3568352,CHEMBL1278697,Antibacterial activity against ESBL-producing Escherichia coli assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969546,=,1,0,=,Activity,%,83.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,83.3
54184,,3568354,CHEMBL1278698,Antibacterial activity against AmpC-producing Escherichia coli assessed as sensitive isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969546,=,1,0,=,Activity,%,88.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,88.9
54185,,3568369,CHEMBL1278694,Antibacterial activity against AmpC-producing Escherichia coli isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969546,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.06
54186,,3568372,CHEMBL1278694,Antibacterial activity against AmpC-producing Escherichia coli isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969546,>,1,1,>,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
54187,,3568379,CHEMBL1278696,Antibacterial activity against ESBL-producing Escherichia coli isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275413,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969546,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
54188,,3569351,CHEMBL1280712,Antimicrobial activity against Leptospira interrogans serovar Canicola isolate 11 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
54189,,3569355,CHEMBL1280701,Antimicrobial activity against Leptospira interrogans serovar Bataviae isolate 1 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54190,,3569584,CHEMBL1279277,Antimicrobial activity against Enterobacter cloacae isolate 1 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.38
54191,,3569585,CHEMBL1279278,Antimicrobial activity against Enterobacter cloacae isolate 18 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.5
54192,,3569586,CHEMBL1279279,Antimicrobial activity against Enterobacter cloacae isolate 140 containing PFGE genetic clone A expressing beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.094,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.094
54193,,3569587,CHEMBL1279280,Antimicrobial activity against Enterobacter cloacae isolate 151 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.5
54194,,3569588,CHEMBL1279281,Antimicrobial activity against Enterobacter cloacae isolate 185 containing PFGE genetic clone A expressing qnrB2 aac(6')-Ib-cr and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.5
54195,,3569589,CHEMBL1279282,Antimicrobial activity against Enterobacter cloacae isolate 293 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.75
54196,,3569590,CHEMBL1279283,Antimicrobial activity against Enterobacter cloacae isolate 533 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.38
54197,,3569591,CHEMBL1279284,Antimicrobial activity against Enterobacter cloacae isolate 622 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.5
54198,,3569592,CHEMBL1279285,Antimicrobial activity against Enterobacter cloacae isolate 625 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.5
54199,,3569593,CHEMBL1279286,Antimicrobial activity against Enterobacter cloacae isolate 656 containing PFGE genetic clone A expressing beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.5
54200,,3569594,CHEMBL1279287,Antimicrobial activity against Enterobacter cloacae isolate 354 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.19
54201,,3569595,CHEMBL1279288,Antimicrobial activity against Enterobacter cloacae isolate 649 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.75
54202,,3569596,CHEMBL1279289,Antimicrobial activity against Enterobacter cloacae isolate 658 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,1.0
54203,,3569597,CHEMBL1279290,Antimicrobial activity against Enterobacter cloacae isolate 781 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.5
54204,,3569598,CHEMBL1279291,Antimicrobial activity against Enterobacter cloacae isolate 837 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.75
54205,,3569599,CHEMBL1279292,Antimicrobial activity against Enterobacter cloacae isolate 4469 containing PFGE genetic clone C expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.5
54206,,3569600,CHEMBL1279293,Antimicrobial activity against Escherichia coli T-622 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
54207,,3569601,CHEMBL1279294,Antimicrobial activity against Escherichia coli T-625 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.094
54208,,3569602,CHEMBL1279295,Antimicrobial activity against Escherichia coli T-781 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
54209,,3569603,CHEMBL1279296,Antimicrobial activity against Escherichia coli GeneHogs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969740,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
54210,,3569712,CHEMBL1280702,Antimicrobial activity against Leptospira interrogans serovar Grippotyphosa isolate 2 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54211,,3569714,CHEMBL1280703,Antimicrobial activity against Leptospira interrogans serovar Icterohaemorrhagiae isolate 3 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54212,,3569718,CHEMBL1280705,Antimicrobial activity against Leptospira interrogans serovar Pyrogenes isolate 5 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54213,,3569721,CHEMBL1280706,Antimicrobial activity against Leptospira weilii isolate 6 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54214,,3569725,CHEMBL1280700,Antimicrobial activity against Leptospira interrogans isolate 7 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54215,,3569736,CHEMBL1280704,Antimicrobial activity against Leptospira interrogans serovar Pomona isolate 4 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.125
54216,,3569742,CHEMBL1280707,Antimicrobial activity against Leptospira weilii isolate 8 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.125
54217,,3569745,CHEMBL1280708,Antimicrobial activity against Leptospira interrogans serovar Icterohaemorrhagiae isolate 9 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.125
54218,,3569748,CHEMBL1280709,Antimicrobial activity against Leptospira interrogans serovar Icterohaemorrhagiae isolate 10 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.125
54219,,3569841,CHEMBL1280710,Antimicrobial activity against Leptospira interrogans serovar Pomona isolate 12 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,<,1,1,<,MIC,ug.mL-1,0.016,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.016
54220,,3569850,CHEMBL1280711,Antimicrobial activity against Leptospira kirschneri serovar Grippotyphosa isolate 13 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275427,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969647,<,1,1,<,MIC,ug.mL-1,0.016,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.016
54221,,3569865,CHEMBL1281631,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275429,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969594,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54222,,3569872,CHEMBL1281630,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275429,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969594,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54223,,3569879,CHEMBL1281629,Antimicrobial activity against community acquired methicillin-resistant Staphylococcus aureus 144 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275429,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969594,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
54224,,3569886,CHEMBL1281628,Antimicrobial activity against community acquired methicillin-resistant Staphylococcus aureus 146 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275429,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969594,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
54225,,3569893,CHEMBL1281627,Antimicrobial activity against community acquired methicillin-resistant Staphylococcus aureus 147 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275429,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969594,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
54226,,3569900,CHEMBL1281626,Antimicrobial activity against hospital acquired methicillin-resistant Staphylococcus aureus 56 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275429,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969594,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54227,,3569907,CHEMBL1281625,Antimicrobial activity against hospital acquired methicillin-resistant Staphylococcus aureus 149 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275429,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969594,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
54228,,3569914,CHEMBL1281624,Antimicrobial activity against hospital acquired methicillin-resistant Staphylococcus aureus 152 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275429,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969594,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54229,,3570159,CHEMBL1278324,Ratio of MIC for Escherichia coli T-622 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene to MIC for Escherichia coli HB101,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969740,=,1,0,=,Ratio,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,2.0
54230,,3570160,CHEMBL1278325,Ratio of MIC for Escherichia coli T-625 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene to MIC for Escherichia coli HB101,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969740,=,1,0,=,Ratio,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,4.0
54231,,3570161,CHEMBL1278326,Ratio of MIC for Escherichia coli T-781 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene to MIC for Escherichia coli HB101,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275468,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969740,=,1,0,=,Ratio,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,2.0
54232,,3570583,CHEMBL1281361,Antimicrobial activity against Staphylococcus aureus CB190 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969685,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54233,,3570584,CHEMBL1281362,Antimicrobial activity against Staphylococcus aureus CB811 harboring quinolone-resistant gyrA S84L mutant gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969685,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54234,,3570585,CHEMBL1281363,Antimicrobial activity against Staphylococcus aureus CB808 harboring quinolone-resistant parC S80F mutant gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969685,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
54235,,3570586,CHEMBL1281364,Antimicrobial activity against Staphylococcus aureus CB814 harboring fluoroquinolone-resistant gyrA S84L and parC S80F mutant genes by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969685,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
54236,,3570587,CHEMBL1281365,Antimicrobial activity against Staphylococcus aureus CB370 harboring rifampin-resistant rpoB H481Y mutant gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969685,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54237,,3570588,CHEMBL1281366,Antimicrobial activity against Staphylococcus aureus CB812 harboring rpo B H481Y and gyrA S84L mutant genes by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969685,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54238,,3570589,CHEMBL1281367,Antimicrobial activity against Staphylococcus aureus CB812 harboring rpoB H481Y and gyrA S80F mutant genes by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969685,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
54239,,3570590,CHEMBL1281368,"Antimicrobial activity against Staphylococcus aureus CB812 harboring rpoB H481Y, gyrA S84L and gyrA S80F mutant genes by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969685,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
54240,,3570826,CHEMBL1280336,Antimicrobial activity against Acinetobacter baumannii by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275474,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969743,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
54241,,3570834,CHEMBL1280336,Antimicrobial activity against Acinetobacter baumannii by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275474,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969743,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,8.0
54242,,3570842,CHEMBL1280336,Antimicrobial activity against Acinetobacter baumannii by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275474,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969743,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
54243,,3570850,CHEMBL1280339,Antimicrobial activity against Acinetobacter baumannii assessed as susceptible isolates by microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275474,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969743,=,1,0,=,Activity,%,35.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,35.0
54244,,3570969,CHEMBL1280507,Antibacterial activity against Pseudomonas aeruginosa PAO1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
54245,,3570970,CHEMBL1280508,Antibacterial activity against beta-lactamase-overproducing Pseudomonas aeruginosa N043 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
54246,,3570971,CHEMBL1280509,Antibacterial activity against OprD-deficient Pseudomonas aeruginosa MR08 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
54247,,3570972,CHEMBL1280510,Antibacterial activity against MexA-MexB-OprM-overproducing Pseudomonas aeruginosa OCR1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
54248,,3570973,CHEMBL1280511,Antibacterial activity against beta-lactamase-overproducing and OprD-deficient Pseudomonas aeruginosa N044 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
54249,,3570974,CHEMBL1280512,Antibacterial activity against beta-lactamase and MexA-MexB-OprM-overproducing Pseudomonas aeruginosa N045 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
54250,,3570975,CHEMBL1280513,Antibacterial activity against MexA-MexB-OprM-overproducing and OprD-deficient Pseudomonas aeruginosa N041 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
54251,,3570976,CHEMBL1280514,Antibacterial activity against Pseudomonas aeruginosa COR6 expressing MexC-MexD-OprJ gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
54252,,3570977,CHEMBL1280515,Antibacterial activity against Pseudomonas aeruginosa N091 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
54253,,3570978,CHEMBL1280516,Antibacterial activity against Pseudomonas aeruginosa N092 expressing MexE-MexD-OprN gene and OprD mutant gene and harboring nfxC mutant gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969843,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
54254,,3570979,CHEMBL1280517,Ratio of MIC for Pseudomonas aeruginosa N043 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000193,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969843,=,1,0,=,Ratio,,0.5,CHEMBL612545,,Unchecked,,,Ratio,,,0.5
54255,,3570980,CHEMBL1280518,Ratio of MIC for Pseudomonas aeruginosa MR08 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000193,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969843,=,1,0,=,Ratio,,1.0,CHEMBL612545,,Unchecked,,,Ratio,,,1.0
54256,,3570981,CHEMBL1280519,Ratio of MIC for Pseudomonas aeruginosa OCR1 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000193,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969843,=,1,0,=,Ratio,,8.0,CHEMBL612545,,Unchecked,,,Ratio,,,8.0
54257,,3570982,CHEMBL1280520,Ratio of MIC for Pseudomonas aeruginosa N044 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000193,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969843,=,1,0,=,Ratio,,0.5,CHEMBL612545,,Unchecked,,,Ratio,,,0.5
54258,,3570983,CHEMBL1280521,Ratio of MIC for Pseudomonas aeruginosa N045 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000193,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969843,=,1,0,=,Ratio,,4.0,CHEMBL612545,,Unchecked,,,Ratio,,,4.0
54259,,3570984,CHEMBL1280522,Ratio of MIC for Pseudomonas aeruginosa N041 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000193,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969843,=,1,0,=,Ratio,,8.0,CHEMBL612545,,Unchecked,,,Ratio,,,8.0
54260,,3570985,CHEMBL1280523,Ratio of MIC for Pseudomonas aeruginosa COR6 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000193,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969843,=,1,0,=,Ratio,,16.0,CHEMBL612545,,Unchecked,,,Ratio,,,16.0
54261,,3570986,CHEMBL1280524,Ratio of MIC for Pseudomonas aeruginosa N092 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000193,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275475,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969843,=,1,0,=,Ratio,,16.0,CHEMBL612545,,Unchecked,,,Ratio,,,16.0
54262,,3571325,CHEMBL1281421,Antibacterial activity against Streptococcus pneumoniae serotype 19F by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54263,,3571326,CHEMBL1281420,Antibacterial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
54264,,3571327,CHEMBL1281419,Antibacterial activity against Streptococcus pneumoniae serotype 6A/C by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54265,,3571328,CHEMBL1281418,Antibacterial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54266,,3571828,CHEMBL1281422,Antibacterial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54267,,3571829,CHEMBL1281423,Antibacterial activity against Streptococcus pneumoniae serotype 23A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54268,,3571830,CHEMBL1281424,Antibacterial activity against Streptococcus pneumoniae serotype 15A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54269,,3571831,CHEMBL1281425,Antibacterial activity against Streptococcus pneumoniae serotype 33 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54270,,3571832,CHEMBL1281426,Antibacterial activity against Streptococcus pneumoniae serotype 22 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54271,,3571833,CHEMBL1281577,Antibacterial activity against Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,100.0
54272,,3571834,CHEMBL1281578,Antibacterial activity against Streptococcus pneumoniae serotype 6A/C assessed as percent susceptible isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,100.0
54273,,3571835,CHEMBL1281579,Antibacterial activity against Streptococcus pneumoniae serotype 3 assessed as percent susceptible isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,97.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,97.0
54274,,3571836,CHEMBL1281580,Antibacterial activity against Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,100.0
54275,,3571837,CHEMBL1281581,Antibacterial activity against Streptococcus pneumoniae serotype 35B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,100.0
54276,,3571838,CHEMBL1281582,Antibacterial activity against Streptococcus pneumoniae serotype 23A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,100.0
54277,,3571839,CHEMBL1281583,Antibacterial activity against Streptococcus pneumoniae serotype 15A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,100.0
54278,,3571840,CHEMBL1281584,Antibacterial activity against Streptococcus pneumoniae serotype 33 assessed as percent susceptible isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54279,,3571841,CHEMBL1281585,Antibacterial activity against Streptococcus pneumoniae serotype 22 assessed as percent susceptible isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,100.0
54280,,3571842,CHEMBL1281586,Antibacterial activity against Streptococcus pneumoniae serotype 19A assessed as percent resistant isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54281,,3571843,CHEMBL1281587,Antibacterial activity against Streptococcus pneumoniae serotype 6A/C assessed as percent resistant isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54282,,3571844,CHEMBL1281588,Antibacterial activity against Streptococcus pneumoniae serotype 3 assessed as percent resistant isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54283,,3571845,CHEMBL1281589,Antibacterial activity against Streptococcus pneumoniae serotype 19F assessed as percent resistant isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54284,,3571846,CHEMBL1281590,Antibacterial activity against Streptococcus pneumoniae serotype 35B assessed as percent resistant isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54285,,3571847,CHEMBL1281591,Antibacterial activity against Streptococcus pneumoniae serotype 23A assessed as percent resistant isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54286,,3571848,CHEMBL1281592,Antibacterial activity against Streptococcus pneumoniae serotype 15A assessed as percent resistant isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54287,,3571849,CHEMBL1281593,Antibacterial activity against Streptococcus pneumoniae serotype 33 assessed as percent resistant isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54288,,3571850,CHEMBL1281594,Antibacterial activity against Streptococcus pneumoniae serotype 22 assessed as percent resistant isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275437,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969596,=,1,1,=,MIC90,ug.mL-1,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.0
54289,,3571961,CHEMBL1278975,Antibacterial activity against Streptococcus viridans clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,100.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,Activity,%,UO_0000187,100.0
54290,,3571969,CHEMBL1278976,Antibacterial activity against Streptococcus constellatus clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,100.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,Activity,%,UO_0000187,100.0
54291,,3571980,CHEMBL1278977,Antibacterial activity against Streptococcus oralis clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,100.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,Activity,%,UO_0000187,100.0
54292,,3571988,CHEMBL1278978,Antibacterial activity against Streptococcus intermedius clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,100.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,Activity,%,UO_0000187,100.0
54293,,3571996,CHEMBL1278979,Antibacterial activity against Streptococcus mitis clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,100.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,Activity,%,UO_0000187,100.0
54294,,3572007,CHEMBL1278980,Antibacterial activity against Streptococcus agalactiae group B clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,99.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,99.0
54295,,3572014,CHEMBL1278981,Antibacterial activity against Streptococcus pyogenes group A clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,98.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,98.0
54296,,3572024,CHEMBL1278982,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,95.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,95.0
54297,,3572035,CHEMBL1278983,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,97.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,97.0
54298,,3572044,CHEMBL1278984,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,969578,=,1,0,=,Activity,%,92.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,92.0
54299,Not Active,3572548,CHEMBL1278996,Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC90,,,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC90,,,
54300,Not Active,3572549,CHEMBL1278996,Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC50,,,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC50,,,
54301,,3572550,CHEMBL1278996,Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,0.12
54302,Not Active,3572584,CHEMBL1278997,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC90,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC90,,,
54303,Not Active,3572585,CHEMBL1278997,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC50,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC50,,,
54304,,3572586,CHEMBL1278997,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC,ug ml-1,UO_0000274,0.12
54305,Not Active,3572620,CHEMBL1278998,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC50,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC50,,,
54306,Not Active,3572621,CHEMBL1278998,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC90,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC90,,,
54307,,3572622,CHEMBL1278998,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,0.12
54308,Not Active,3572655,CHEMBL1278999,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC50,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC50,,,
54309,Not Active,3572656,CHEMBL1278999,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC90,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC90,,,
54310,,3572658,CHEMBL1278999,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC,ug ml-1,UO_0000274,0.12
54311,Not Active,3572691,CHEMBL1279000,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC90,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC90,,,
54312,,3572695,CHEMBL1279000,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.12
54313,Not Active,3572696,CHEMBL1279000,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,969578,,1,0,,MIC50,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC50,,,
54314,,3572728,CHEMBL1279001,Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
54315,,3572729,CHEMBL1279001,Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.5
54316,,3572730,CHEMBL1279001,Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.12
54317,,3572764,CHEMBL1279002,Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,1.0
54318,,3572765,CHEMBL1279002,Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
54319,,3572766,CHEMBL1279002,Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.12
54320,,3572800,CHEMBL1279003,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
54321,,3572801,CHEMBL1279003,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
54322,,3572802,CHEMBL1279003,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54323,,3572836,CHEMBL1279004,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
54324,,3572837,CHEMBL1279004,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
54325,,3572838,CHEMBL1279004,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54326,,3573105,CHEMBL1282118,Antibacterial activity against Serratia marcescens obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC50,ug ml-1,UO_0000274,0.06
54327,,3573113,CHEMBL1282117,Antibacterial activity against Salmonella spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL614446,Salmonella,Salmonella,590.0,,MIC50,ug ml-1,UO_0000274,0.06
54328,,3573121,CHEMBL1282116,Antibacterial activity against Providencia stuartii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC50,ug ml-1,UO_0000274,0.06
54329,,3573129,CHEMBL1282115,Antibacterial activity against Proteus vulgaris obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC50,ug ml-1,UO_0000274,0.06
54330,,3573137,CHEMBL1282114,Antibacterial activity against Proteus penneri obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.06
54331,,3573145,CHEMBL1282113,Antibacterial activity against Proteus mirabilis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,0.06
54332,,3573153,CHEMBL1282112,Antibacterial activity against Morganella morganii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC50,ug ml-1,UO_0000274,1.0
54333,,3573161,CHEMBL1282111,Antibacterial activity against Klebsiella pneumoniae obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.06
54334,,3573169,CHEMBL1282110,Antibacterial activity against Escherichia coli obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.03
54335,,3573177,CHEMBL1282109,Antibacterial activity against Enterobacter cloacae obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,0.06
54336,,3573185,CHEMBL1282108,Antibacterial activity against Enterobacter amnigenus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.06
54337,,3573193,CHEMBL1282107,Antibacterial activity against Citrobacter freundii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC50,ug ml-1,UO_0000274,0.06
54338,,3573201,CHEMBL1282106,Antibacterial activity against Citrobacter braakii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.06
54339,,3573222,CHEMBL1279005,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
54340,,3573223,CHEMBL1279005,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
54341,,3573224,CHEMBL1279005,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969578,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54342,,3573552,CHEMBL1279996,Antibacterial activity against Klebsiella oxytoca obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.015
54343,,3573560,CHEMBL1279995,Antibacterial activity against Enterobacter aerogenes obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.015
54344,,3573568,CHEMBL1279991,Antibacterial activity against Stenotrophomonas maltophilia obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.06
54345,,3573576,CHEMBL1279990,Antibacterial activity against Pseudomonas fluorescens obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,MIC,ug ml-1,UO_0000274,0.06
54346,,3573584,CHEMBL1279989,Antibacterial activity against Acinetobacter baumannii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
54347,,3573592,CHEMBL1282118,Antibacterial activity against Serratia marcescens obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.015
54348,,3573600,CHEMBL1282117,Antibacterial activity against Salmonella spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL614446,Salmonella,Salmonella,590.0,,MIC,ug ml-1,UO_0000274,0.015
54349,,3573608,CHEMBL1282116,Antibacterial activity against Providencia stuartii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC,ug ml-1,UO_0000274,0.015
54350,,3573616,CHEMBL1282115,Antibacterial activity against Proteus vulgaris obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.015
54351,,3573624,CHEMBL1282114,Antibacterial activity against Proteus penneri obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.015
54352,,3573632,CHEMBL1282113,Antibacterial activity against Proteus mirabilis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.03
54353,,3573640,CHEMBL1282112,Antibacterial activity against Morganella morganii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.03
54354,,3573648,CHEMBL1282111,Antibacterial activity against Klebsiella pneumoniae obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
54355,,3573656,CHEMBL1282110,Antibacterial activity against Escherichia coli obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
54356,,3573664,CHEMBL1282109,Antibacterial activity against Enterobacter cloacae obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
54357,,3573672,CHEMBL1282108,Antibacterial activity against Enterobacter amnigenus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.015
54358,,3573680,CHEMBL1282107,Antibacterial activity against Citrobacter freundii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.015
54359,,3573688,CHEMBL1282106,Antibacterial activity against Citrobacter braakii obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,>,1,1,>,MIC,ug.mL-1,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.015
54360,,3573695,CHEMBL1282105,Antibacterial activity against Micrococcus spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612937,Micrococcus,Micrococcus,1269.0,,MIC90,ug ml-1,UO_0000274,4.0
54361,,3573704,CHEMBL1282104,Antibacterial activity against Lactococcus lactis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,MIC90,ug ml-1,UO_0000274,4.0
54362,,3573713,CHEMBL1282103,Antibacterial activity against Gemella spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,4.0
54363,,3573722,CHEMBL1282102,Antibacterial activity against Gemella morbillorum obtained from complicated skin and skin structure infections by RapID ANA system,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,4.0
54364,,3573731,CHEMBL1281981,Antibacterial activity against Bacillus spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,MIC90,ug ml-1,UO_0000274,4.0
54365,,3573740,CHEMBL1281980,Antibacterial activity against Aerococcus viridans obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,4.0
54366,,3573749,CHEMBL1281979,Antibacterial activity against Staphylococcus intermedius obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614422,Staphylococcus intermedius,Staphylococcus intermedius,1285.0,,MIC90,ug ml-1,UO_0000274,0.12
54367,,3573758,CHEMBL1281978,Antibacterial activity against Streptococcus mitis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC90,ug ml-1,UO_0000274,0.12
54368,,3573770,CHEMBL1281977,Antibacterial activity against Streptococcus constellatus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC90,ug ml-1,UO_0000274,1.0
54369,,3573776,CHEMBL1282105,Antibacterial activity against Micrococcus spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612937,Micrococcus,Micrococcus,1269.0,,MIC50,ug ml-1,UO_0000274,0.5
54370,,3573785,CHEMBL1282104,Antibacterial activity against Lactococcus lactis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,MIC50,ug ml-1,UO_0000274,0.5
54371,,3573794,CHEMBL1282103,Antibacterial activity against Gemella spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
54372,,3573803,CHEMBL1282102,Antibacterial activity against Gemella morbillorum obtained from complicated skin and skin structure infections by RapID ANA system,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
54373,,3573812,CHEMBL1281981,Antibacterial activity against Bacillus spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612428,Bacillus,Bacillus,1386.0,,MIC50,ug ml-1,UO_0000274,0.5
54374,,3573821,CHEMBL1281980,Antibacterial activity against Aerococcus viridans obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
54375,,3573830,CHEMBL1281979,Antibacterial activity against Staphylococcus intermedius obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.03,CHEMBL614422,Staphylococcus intermedius,Staphylococcus intermedius,1285.0,,MIC50,ug ml-1,UO_0000274,0.03
54376,,3573839,CHEMBL1281978,Antibacterial activity against Streptococcus mitis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC50,ug.mL-1,0.03,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC50,ug ml-1,UO_0000274,0.03
54377,,3573851,CHEMBL1281977,Antibacterial activity against Streptococcus constellatus obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC50,ug ml-1,UO_0000274,0.25
54378,,3573857,CHEMBL1282105,Antibacterial activity against Micrococcus spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL612937,Micrococcus,Micrococcus,1269.0,,MIC,ug ml-1,UO_0000274,0.06
54379,,3573866,CHEMBL1282104,Antibacterial activity against Lactococcus lactis obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,MIC,ug ml-1,UO_0000274,0.06
54380,,3573875,CHEMBL1282103,Antibacterial activity against Gemella spp. obtained from complicated skin and skin structure infections by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1275492,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970577,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
54381,,3591087,CHEMBL1291910,Antibacterial activity against Staphylococcus aureus ATCC 259223 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
54382,,3591130,CHEMBL1291911,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-1 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
54383,,3591173,CHEMBL1291912,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-2 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
54384,,3591216,CHEMBL1292563,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-2 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
54385,,3591259,CHEMBL1292564,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-3 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
54386,,3591302,CHEMBL1292565,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-4 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
54387,,3591720,CHEMBL1292566,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-3 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
54388,,3591763,CHEMBL1292567,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
54389,,3591806,CHEMBL1292568,Antibacterial activity against Streptococcus pneumoniae 08-2 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
54390,,3591849,CHEMBL1292569,Antibacterial activity against Streptococcus pneumoniae 08-4 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
54391,,3591892,CHEMBL1292570,Antibacterial activity against Enterococcus faecium 08-2 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
54392,,3591935,CHEMBL1292571,Antibacterial activity against Enterococcus faecium 08-7 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,2.0
54393,,3591978,CHEMBL1292572,Antibacterial activity against Enterococcus faecalis 08-10 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
54394,,3592021,CHEMBL1292573,Antibacterial activity against Enterococcus faecalis 08-12 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
54395,,3592064,CHEMBL1292574,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
54396,,3592483,CHEMBL1292575,Antibacterial activity against Escherichia coli 08-21 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
54397,,3592526,CHEMBL1292576,Antibacterial activity against Escherichia coli 08-22 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
54398,,3592569,CHEMBL1292577,Antibacterial activity against Klebsiella pneumoniae 09-21 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
54399,,3592612,CHEMBL1292578,Antibacterial activity against Klebsiella pneumoniae 09-22 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
54400,,3592655,CHEMBL1292579,Antibacterial activity against Klebsiella pneumoniae 09-23 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
54401,,3592698,CHEMBL1292580,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
54402,,3592741,CHEMBL1292581,Antibacterial activity against Pseudomonas aeruginosa 09-32 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
54403,,3592784,CHEMBL1292582,Antibacterial activity against Pseudomonas aeruginosa 09-33 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
54404,,3593173,CHEMBL1292583,Antibacterial activity against Pseudomonas aeruginosa 09-34 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
54405,,3593216,CHEMBL1292584,Antibacterial activity against Pseudomonas aeruginosa 09-35 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287651,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974547,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
54406,,3602370,CHEMBL1290869,Anticancer activity against human U373MG after 5 days by MTT assay,F,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287781,Bioorg Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,976374,=,1,1,=,IC50,nM,188000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,IC50,uM,UO_0000065,188.0
54407,Dose-dependent effect,3602401,CHEMBL1291080,Anticancer activity against human U373MG after 3 to 5 days by MTT assay,F,BAO_0000375,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1287781,Bioorg Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,976374,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
54408,Active,3636227,CHEMBL1614538,"PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus. (Class of assay: confirmatory) [Related pubchem assays: 1900 (Counter Screen), 1677 (Project Summary), 1902 (Retest at Dose), 1662 (Primary HTS)]",F,BAO_0000188,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,=,7,1,=,EC50,nM,911.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,EC50,um,UO_0000065,0.911
54409,Active,3766260,CHEMBL1613983,"PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)]",F,BAO_0000188,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,=,7,1,=,EC50,nM,2103.0,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,EC50,um,UO_0000065,2.103
54410,Active,4126697,CHEMBL1614455,"PUBCHEM_BIOASSAY: A Counter Screen to identiry small molecule screen for inhibitors of the PhoP region in Salmonella Typhimurium. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1863, 1981, 1874 ]",F,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,=,7,1,=,IC50,nM,370.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.37
54411,Inconclusive,4243696,CHEMBL1614459,PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1150792,=,7,1,=,Potency,nM,2310.9,CHEMBL612545,,Unchecked,,,Potency,um,UO_0000065,2.3109
54412,Active,4302554,CHEMBL1614127,"PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhimurium using a modified counterscreen. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1863, 1874 ]",F,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,<,7,1,<,IC50,nM,230.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.23
54413,Active,4678562,CHEMBL1613789,"PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella Typhimurium. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1981, 1874 ]",F,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,<,7,1,<,IC50,nM,230.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.23
54414,Active,4686458,CHEMBL1613791,"PUBCHEM_BIOASSAY: A counter screen for small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 2252, 1985 ]",F,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,=,7,1,=,IC50,nM,690.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.69
54415,Active,4921540,CHEMBL1614064,"PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)]",F,BAO_0000188,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,=,7,1,=,EC50,nM,1546.0,CHEMBL1293228,Streptococcus pyogenes serotype M1,Streptokinase A,301447.0,,EC50,um,UO_0000065,1.546
54416,Active,4988704,CHEMBL1614100,"PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1864, 2252, 1985 ]",F,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,<,7,1,<,IC50,nM,230.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.23
54417,Active,5019793,CHEMBL1613892,PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhi using a modified counterscreen. (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1201862,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1212704,<,7,1,<,IC50,nM,230.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.23
54418,,5080627,CHEMBL1614672,Fraction unbound in human after iv administration,A,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1310732,=,1,1,=,Fu,,0.75,CHEMBL3879801,,NON-PROTEIN TARGET,,,fu,,,0.75
54419,,5081075,CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1310732,=,1,1,=,Vdss,L.kg-1,1.2,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,1.2
54420,,5081478,CHEMBL1614671,Clearance in human after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1310732,=,1,1,=,CL,mL.min-1.kg-1,1.9,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,1.9
54421,,5082781,CHEMBL1614674,Half life in human after iv administration,A,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1310732,=,1,1,=,T1/2,hr,8.8,CHEMBL612558,,ADMET,,,t1/2,h,UO_0000032,8.8
54422,,5085028,CHEMBL1636902,Antibacterial activity against Streptococcus pneumoniae U2A1414 harboring gyrA Glu85Lys parC Ser79Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
54423,,5085029,CHEMBL1636901,Antibacterial activity against Streptococcus pneumoniae U2A1060 harboring gyrA Ser81Phe parC Asp83His mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
54424,,5085030,CHEMBL1636899,Antibacterial activity against Streptococcus pneumoniae R6 Tr10 harboring gyrA Ser81Tyr parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
54425,,5085031,CHEMBL1636749,Antibacterial activity against Streptococcus pneumoniae U2A1681 harboring parC Ser79Tyr Asp83Ala mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
54426,,5085032,CHEMBL1636743,Antibacterial activity against Streptococcus pneumoniae H548 clinical isolate harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
54427,,5085047,CHEMBL1636916,Antibacterial activity against Streptococcus pneumoniae U2A1411 harboring parC Asp83Gly mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
54428,,5085053,CHEMBL1636915,Antibacterial activity against Streptococcus pneumoniae U2A1693 harboring parC Asp83Asn mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
54429,,5085054,CHEMBL1636913,Antibacterial activity against Streptococcus pneumoniae U2A1053 harboring parC Ser79Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
54430,,5085055,CHEMBL1636912,Antibacterial activity against Streptococcus pneumoniae R6 Tr1 harboring parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
54431,,5085056,CHEMBL1636910,Antibacterial activity against Streptococcus pneumoniae U2A1266 harboring gyrA Ser81Cys mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
54432,,5085057,CHEMBL1636909,Antibacterial activity against Streptococcus pneumoniae U2A1051 harboring gyrA Ser81Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
54433,,5085058,CHEMBL1636908,Antibacterial activity against Streptococcus pneumoniae U2A1050 harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
54434,,5085069,CHEMBL1636914,Antibacterial activity against Streptococcus pneumoniae U2A1413 harboring parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
54435,,5085070,CHEMBL1636907,Antibacterial activity against Streptococcus pneumoniae U2A1686 harboring gyrA Glu85Lys mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
54436,,5085071,CHEMBL1636906,Antibacterial activity against Streptococcus pneumoniae R6 Tr6 harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
54437,,5085072,CHEMBL1636905,Antibacterial activity against Streptococcus pneumoniae CP1000 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
54438,,5085073,CHEMBL1636904,Antibacterial activity against Streptococcus pneumoniae R6 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
54439,,5085074,CHEMBL1636903,Antibacterial activity against Streptococcus pneumoniae CIP104485 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
54440,,5085101,CHEMBL1636921,Antibacterial activity against Streptococcus pneumoniae U2A1414 harboring gyrA Glu85Lys parC Ser79Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
54441,,5085928,CHEMBL1634884,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87, parC I80, G84 and parE A458 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,200.0
54442,,5085930,CHEMBL1634883,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC I80, G84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
54443,,5085931,CHEMBL1634882,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87, parC I80 and parE A458 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
54444,,5085932,CHEMBL1634881,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC I80 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
54445,,5085933,CHEMBL1634880,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC K84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
54446,,5085934,CHEMBL1634878,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83,N87,gyrB V456, parC I80 and parE A458 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
54447,,5085935,CHEMBL1634879,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
54448,,5085936,CHEMBL1634877,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80, K84 and parE D460 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
54449,,5085937,CHEMBL1634876,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, gyrB T471 and parC I80, G84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,30.0
54450,,5085938,CHEMBL1634875,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC R80, V84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
54451,,5085939,CHEMBL1634873,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80 and parE A548 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,20.0
54452,,5085940,CHEMBL1634874,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC I80, G84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
54453,,5085941,CHEMBL1634872,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80 and parE M464 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
54454,,5085942,CHEMBL1634871,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC I80 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
54455,,5085943,CHEMBL1634870,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC K84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
54456,,5085944,CHEMBL1634869,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
54457,,5085945,CHEMBL1634868,Antimicrobial activity against Escherichia coli K-12 harboring parE A458 mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,0.034,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.034
54458,,5085946,CHEMBL1634866,Antimicrobial activity against Escherichia coli K-12 harboring gyrA A83 mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,0.168,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.168
54459,,5085948,CHEMBL1634867,Antimicrobial activity against Escherichia coli K-12 harboring by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313902,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
54460,,5086001,CHEMBL1634885,Antimicrobial activity against Escherichia coli ATCC 25922 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313906,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
54461,,5086002,CHEMBL1634886,Antimicrobial activity against fluoroquinolone-sensitive Escherichia coli clinical isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313906,=,1,1,=,MIC,ug.mL-1,0.042,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.042
54462,,5086003,CHEMBL1634886,Antimicrobial activity against fluoroquinolone-sensitive Escherichia coli clinical isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313906,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
54463,,5086004,CHEMBL1634887,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313906,=,1,1,=,MIC,ug.mL-1,39.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,39.0
54464,,5086005,CHEMBL1634888,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli clinical isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313906,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
54465,,5086535,CHEMBL1635917,Antibacterial activity against Staphylococcus aureus SRR2a selected at 2 times MIC of tomopenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
54466,,5086536,CHEMBL1635918,Ratio of MIC for Staphylococcus aureus SRR2a to MIC for Staphylococcus aureus ATCC 6538P,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
54467,,5086537,CHEMBL1635919,Antibacterial activity against Staphylococcus aureus SIR2a selected at 2 times MIC of imipenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
54468,,5086538,CHEMBL1636766,Ratio of MIC for Staphylococcus aureus SIR2a selected at 2 times MIC of imipenem to MIC for Staphylococcus aureus ATCC 6538P,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
54469,,5086539,CHEMBL1636767,Antibacterial activity against Staphylococcus aureus SMR2a selected at 2 times MIC of meropenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
54470,,5086540,CHEMBL1636768,Ratio of MIC for Staphylococcus aureus SMR2a to MIC for Staphylococcus aureus ATCC 6538P,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
54471,,5086541,CHEMBL1636769,Antibacterial activity against Staphylococcus aureus SMR4a selected at 2 times MIC of meropenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
54472,,5086542,CHEMBL1636770,Ratio of MIC for Staphylococcus aureus SMR4a to MIC for Staphylococcus aureus ATCC 6538P,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
54473,,5086543,CHEMBL1636771,Antibacterial activity against Escherichia coli ERR2a selected at 2 times MIC of tomopenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54474,,5086544,CHEMBL1636772,Ratio of MIC for Escherichia coli ERR2a selected to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54475,,5086545,CHEMBL1636773,Antibacterial activity against Escherichia coli ERR2b selected at 2 times MIC of tomopenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
54476,,5086546,CHEMBL1636774,Ratio of MIC for Escherichia coli ERR2b to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
54477,,5086547,CHEMBL1636775,Antibacterial activity against Escherichia coli ERR4a selected at 4 times MIC of tomopenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54478,,5086548,CHEMBL1636776,Ratio of MIC for Escherichia coli ERR4a to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54479,,5086549,CHEMBL1636777,Antibacterial activity against Escherichia coli ERR8a selected at 8 times MIC of tomopenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54480,,5086550,CHEMBL1636778,Ratio of MIC for Escherichia coli ERR8a to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54481,,5086551,CHEMBL1636779,Antibacterial activity against Escherichia coli EIR2a selected at 2 times MIC of imipenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54482,,5086552,CHEMBL1636780,Ratio of MIC for Escherichia coli EIR2a to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54483,,5086553,CHEMBL1636781,Antibacterial activity against Escherichia coli EIR2b selected at 2 times MIC of imipenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54484,,5086554,CHEMBL1636782,Ratio of MIC for Escherichia coli EIR2b to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54485,,5086555,CHEMBL1636783,Antibacterial activity against Escherichia coli EIR4a selected at 4 times MIC of imipenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54486,,5086556,CHEMBL1636784,Ratio of MIC for Escherichia coli EIR4a to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54487,,5086557,CHEMBL1636785,Antibacterial activity against Escherichia coli EIR4b selected at 4 times MIC of imipenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54488,,5086558,CHEMBL1636786,Ratio of MIC for Escherichia coli EIR4b to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54489,,5086559,CHEMBL1636787,Antibacterial activity against Escherichia coli EIR8a selected at 8 times MIC of imipenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54490,,5086560,CHEMBL1636788,Ratio of MIC for Escherichia coli EIR8a to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54491,,5086561,CHEMBL1636789,Antibacterial activity against Escherichia coli EMR2a selected at 2 times MIC of meropenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54492,,5086562,CHEMBL1636790,Ratio of MIC for Escherichia coli EMR2a to MIC for Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54493,,5086563,CHEMBL1636791,Antibacterial activity against Pseudomonas aeruginosa PRR4a selected at 4 times MIC of tomopenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
54494,,5086564,CHEMBL1636792,Ratio of MIC for Pseudomonas aeruginosa PRR4a to MIC for Pseudomonas aeruginosa ATCC 15692,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
54495,,5086565,CHEMBL1636793,Antibacterial activity against Pseudomonas aeruginosa PIR2a selected at 2 times MIC of imipenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
54496,,5086566,CHEMBL1636794,Ratio of MIC for Pseudomonas aeruginosa PIR2a to MIC for Pseudomonas aeruginosa ATCC 15692,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
54497,,5086567,CHEMBL1636795,Antibacterial activity against Pseudomonas aeruginosa PMR2a selected at 2 times MIC of meropenem by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
54498,,5086568,CHEMBL1636796,Ratio of MIC for Pseudomonas aeruginosa PMR2a to MIC for Pseudomonas aeruginosa ATCC 15692,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629655,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315571,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
54499,,5086685,CHEMBL1633449,Antimicrobial activity against Escherichia coli J53 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
54500,,5086686,CHEMBL1633450,"Antimicrobial activity against Klebsiella pneumoniae D10 expressing aac(6')-Ib-cr, qnrB4, CTX-M-1G and DHA-1 genes by Etest",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
54501,,5086687,CHEMBL1633451,Antimicrobial activity against Escherichia coli J53 transformed with pHND1 carrying DHA-1 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
54502,,5086688,CHEMBL1633452,Antimicrobial activity against Klebsiella pneumoniae D24 expressing aac(6')-Ib-cr and CTX-M-9G genes by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
54503,,5086689,CHEMBL1633453,Antimicrobial activity against Escherichia coli J53 transformed with pHND2 carrying qnrB6 and CTX-M-9G genes by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
54504,,5086690,CHEMBL1633454,Antimicrobial activity against Citrobacter freundii D26 expressing qnrB6 and CTX-M-9G genes by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,2.0
54505,,5086691,CHEMBL1633455,Antimicrobial activity against Escherichia coli J53 transformed with pHND3 carrying qnrB6 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
54506,,5086692,CHEMBL1633456,Antimicrobial activity against Escherichia coli Du19 expressing qnrB6 and CTX-M-9G genes by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
54507,,5086693,CHEMBL1633457,Antimicrobial activity against Escherichia coli J53 transformed with pHNDU1 carrying qnrB6 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
54508,,5086694,CHEMBL1633458,"Antimicrobial activity against Escherichia coli PA11 expressing aac(6')-Ib-cr, qnrS1 and qepA genes by Etest",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
54509,,5086695,CHEMBL1634250,Antimicrobial activity against Escherichia coli J53 transformed with pHNPA1 carrying qnrB6 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313924,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
54510,,5087269,CHEMBL1636370,Antimicrobial activity against Klebsiella pneumoniae E353 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
54511,,5087270,CHEMBL1636371,Antimicrobial activity against Klebsiella pneumoniae E354 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
54512,,5087271,CHEMBL1636380,Antimicrobial activity against Klebsiella pneumoniae E356 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
54513,,5087272,CHEMBL1636381,Antimicrobial activity against Klebsiella pneumoniae E362 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
54514,,5087273,CHEMBL1636382,Antimicrobial activity against Klebsiella pneumoniae E363 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
54515,,5087274,CHEMBL1636383,Antimicrobial activity against Klebsiella pneumoniae E364 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
54516,,5087275,CHEMBL1636384,Antimicrobial activity against Klebsiella pneumoniae E366 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
54517,,5087276,CHEMBL1636385,Antimicrobial activity against Klebsiella pneumoniae E367 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
54518,,5087277,CHEMBL1636386,Antimicrobial activity against Klebsiella pneumoniae E368 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
54519,,5087278,CHEMBL1636387,Antimicrobial activity against Klebsiella pneumoniae E369 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
54520,,5087279,CHEMBL1636388,Antimicrobial activity against Klebsiella pneumoniae E370 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
54521,,5087280,CHEMBL1636389,Antimicrobial activity against Klebsiella pneumoniae E371 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
54522,,5087281,CHEMBL1636390,Antimicrobial activity against Klebsiella pneumoniae E372 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
54523,,5087282,CHEMBL1636391,Antimicrobial activity against Klebsiella pneumoniae E411 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
54524,,5087283,CHEMBL1636392,Antimicrobial activity against Klebsiella pneumoniae E418 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
54525,,5087284,CHEMBL1636393,Antimicrobial activity against Klebsiella pneumoniae E422 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
54526,,5087285,CHEMBL1636394,Antimicrobial activity against Klebsiella pneumoniae E426 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
54527,,5087286,CHEMBL1636395,Antimicrobial activity against Klebsiella pneumoniae E427 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
54528,,5087287,CHEMBL1636396,Antimicrobial activity against Klebsiella pneumoniae E428 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
54529,,5087288,CHEMBL1636397,Antimicrobial activity against Klebsiella pneumoniae E431 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
54530,,5087289,CHEMBL1636398,Antimicrobial activity against Klebsiella pneumoniae E432 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
54531,,5087290,CHEMBL1636399,Antimicrobial activity against Klebsiella pneumoniae E433 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
54532,,5087291,CHEMBL1636400,Antimicrobial activity against Escherichia coli E341 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
54533,,5087292,CHEMBL1636401,Antimicrobial activity against Escherichia coli E342 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
54534,,5087293,CHEMBL1636402,Antimicrobial activity against Escherichia coli E346 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54535,,5087294,CHEMBL1636403,Antimicrobial activity against Escherichia coli E351 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
54536,,5087295,CHEMBL1636404,Antimicrobial activity against Escherichia coli E393 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
54537,,5087296,CHEMBL1636405,Antimicrobial activity against Escherichia coli E394 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
54538,,5087297,CHEMBL1636406,Antimicrobial activity against Escherichia coli E395 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
54539,,5087298,CHEMBL1636407,Antimicrobial activity against Escherichia coli E396 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
54540,,5087299,CHEMBL1636408,Antimicrobial activity against Escherichia coli E408 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
54541,,5087300,CHEMBL1636409,Antimicrobial activity against Escherichia coli E409 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
54542,,5087301,CHEMBL1636410,Antimicrobial activity against Escherichia coli E410 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
54543,,5087302,CHEMBL1636411,Antimicrobial activity against Escherichia coli E412 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
54544,,5087303,CHEMBL1636412,Antimicrobial activity against Escherichia coli E413 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
54545,,5087304,CHEMBL1636413,Antimicrobial activity against Escherichia coli E424 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
54546,,5087305,CHEMBL1636414,Antimicrobial activity against Escherichia coli E425 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
54547,,5087306,CHEMBL1637235,Antimicrobial activity against Escherichia coli E430 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
54548,,5087307,CHEMBL1637236,Antimicrobial activity against Escherichia coli E434 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
54549,,5087308,CHEMBL1637237,Antimicrobial activity against Escherichia coli E435 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
54550,,5087309,CHEMBL1637238,Antimicrobial activity against Escherichia coli E436 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
54551,,5087310,CHEMBL1637239,Antimicrobial activity against Escherichia coli E437 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54552,,5087311,CHEMBL1637240,Antimicrobial activity against Escherichia coli E438 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
54553,,5087312,CHEMBL1637241,Antimicrobial activity against Escherichia coli E439 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
54554,,5087313,CHEMBL1637242,Antimicrobial activity against Enterobacter cloacae E373 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
54555,,5087314,CHEMBL1637243,Antimicrobial activity against Enterobacter cloacae E397 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,16.0
54556,,5087315,CHEMBL1637244,Antimicrobial activity against Citrobacter freundii E384 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.125
54557,,5087316,CHEMBL1637433,Antimicrobial activity against Citrobacter freundii E400 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,32.0
54558,,5087317,CHEMBL1637434,Antimicrobial activity against Pseudomonas aeruginosa P330 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
54559,,5087318,CHEMBL1637435,Antimicrobial activity against Pseudomonas aeruginosa P335 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629611,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312983,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
54560,,5087325,CHEMBL1637250,Antimicrobial activity against Escherichia coli extended-spectrum beta-lactamase producing isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
54561,,5087334,CHEMBL1637251,Antimicrobial activity against Klebsiella pneumoniae extended-spectrum beta-lactamase producing isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.12
54562,,5087343,CHEMBL1637252,Antimicrobial activity against Proteus mirabilis extended-spectrum beta-lactamase producing isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.12
54563,,5088094,CHEMBL1637253,Antimicrobial activity against Escherichia coli expressing beta-lactamase SHV by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
54564,,5088103,CHEMBL1637254,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on single determinant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
54565,,5088112,CHEMBL1637249,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on multiple determinants,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
54566,,5088121,CHEMBL1637248,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX and SHV by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
54567,,5088130,CHEMBL1637246,Antimicrobial activity against Escherichia coli expressing beta-lactamase AmpC by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
54568,,5088139,CHEMBL1637245,Antimicrobial activity against Escherichia coli expressing beta-lactamase AmpC and extended-spectrum beta-lactamase by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
54569,,5088148,CHEMBL1637255,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV by Etest based on single determinant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.12
54570,,5088157,CHEMBL1637256,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV by Etest based on multiple determinants,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.12
54571,,5088166,CHEMBL1637257,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on single determinant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.12
54572,,5088175,CHEMBL1637247,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on multiple determinants,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.12
54573,,5088184,CHEMBL1637258,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV and CTX by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.12
54574,,5088193,CHEMBL1637259,Antimicrobial activity against Klebsiella pneumoniae expressing extended-spectrum beta-lactamase and beta-lactamase AmpC by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
54575,,5088202,CHEMBL1637260,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase DHA by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
54576,,5088211,CHEMBL1637261,Antimicrobial activity against Proteus mirabilis expressing extended-spectrum beta-lactamase by Etest based on single determinant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.12
54577,,5088220,CHEMBL1637262,Antimicrobial activity against Proteus mirabilis expressing extended-spectrum beta-lactamase by Etest based on multiple determinants,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,2.0
54578,,5088229,CHEMBL1637263,Antimicrobial activity against Proteus mirabilis expressing beta-lactamase AmpC by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,4.0
54579,,5088238,CHEMBL1637250,Antimicrobial activity against Escherichia coli extended-spectrum beta-lactamase producing isolate by Etest,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
54580,,5088247,CHEMBL1637250,Antimicrobial activity against Escherichia coli extended-spectrum beta-lactamase producing isolate by Etest,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
54581,,5088256,CHEMBL1637251,Antimicrobial activity against Klebsiella pneumoniae extended-spectrum beta-lactamase producing isolate by Etest,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,2.0
54582,,5088265,CHEMBL1637251,Antimicrobial activity against Klebsiella pneumoniae extended-spectrum beta-lactamase producing isolate by Etest,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,16.0
54583,,5088274,CHEMBL1637252,Antimicrobial activity against Proteus mirabilis extended-spectrum beta-lactamase producing isolate by Etest,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,8.0
54584,,5088283,CHEMBL1637252,Antimicrobial activity against Proteus mirabilis extended-spectrum beta-lactamase producing isolate by Etest,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,16.0
54585,,5088292,CHEMBL1637254,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on single determinant,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
54586,,5088301,CHEMBL1637254,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on single determinant,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
54587,,5088310,CHEMBL1637249,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on multiple determinants,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
54588,,5088319,CHEMBL1637249,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on multiple determinants,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
54589,,5088328,CHEMBL1637248,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX and SHV by Etest,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
54590,,5088337,CHEMBL1637248,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX and SHV by Etest,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
54591,,5088346,CHEMBL1637245,Antimicrobial activity against Escherichia coli expressing beta-lactamase AmpC and extended-spectrum beta-lactamase by Etest,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
54592,,5088355,CHEMBL1637245,Antimicrobial activity against Escherichia coli expressing beta-lactamase AmpC and extended-spectrum beta-lactamase by Etest,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
54593,,5088364,CHEMBL1637255,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV by Etest based on single determinant,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.5
54594,,5088373,CHEMBL1637255,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV by Etest based on single determinant,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,16.0
54595,,5088382,CHEMBL1637257,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on single determinant,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,4.0
54596,,5088391,CHEMBL1637257,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on single determinant,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,16.0
54597,,5088400,CHEMBL1637247,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on multiple determinants,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,4.0
54598,,5088409,CHEMBL1637247,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on multiple determinants,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,16.0
54599,,5088418,CHEMBL1637258,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV and CTX by Etest,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.5
54600,,5088427,CHEMBL1637258,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV and CTX by Etest,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312990,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,16.0
54601,,5090753,CHEMBL1634700,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54602,,5090758,CHEMBL1634700,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
54603,,5090763,CHEMBL1634700,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54604,,5090768,CHEMBL1633983,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
54605,,5090772,CHEMBL1633983,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
54606,,5090776,CHEMBL1633983,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54607,,5090782,CHEMBL1633980,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54608,,5090785,CHEMBL1633980,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
54609,,5090788,CHEMBL1633980,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54610,,5090798,CHEMBL1633977,Antimicrobial activity against Enterococcus avium clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612354,Enterococcus avium,Enterococcus avium,33945.0,,MIC50,ug ml-1,UO_0000274,2.0
54611,,5090803,CHEMBL1633977,Antimicrobial activity against Enterococcus avium clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL612354,Enterococcus avium,Enterococcus avium,33945.0,,MIC,ug ml-1,UO_0000274,0.5
54612,,5090808,CHEMBL1633977,Antimicrobial activity against Enterococcus avium clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612354,Enterococcus avium,Enterococcus avium,33945.0,,MIC90,ug ml-1,UO_0000274,2.0
54613,,5090814,CHEMBL1633974,Antimicrobial activity against vancomycin-resistant Enterococcus faecium clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
54614,,5090818,CHEMBL1633974,Antimicrobial activity against vancomycin-resistant Enterococcus faecium clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,16.0
54615,,5090822,CHEMBL1633974,Antimicrobial activity against vancomycin-resistant Enterococcus faecium clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
54616,,5090826,CHEMBL1633856,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,2.0
54617,,5090831,CHEMBL1633856,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
54618,,5090837,CHEMBL1633856,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
54619,,5090842,CHEMBL1633853,Antimicrobial activity against Enterococcus faecium clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,4.0
54620,,5090847,CHEMBL1633853,Antimicrobial activity against Enterococcus faecium clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
54621,,5090851,CHEMBL1633853,Antimicrobial activity against Enterococcus faecium clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.5
54622,,5090857,CHEMBL1633850,Antimicrobial activity against Enterococcus faecalis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
54623,,5090863,CHEMBL1633850,Antimicrobial activity against Enterococcus faecalis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
54624,,5090866,CHEMBL1633850,Antimicrobial activity against Enterococcus faecalis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
54625,,5090872,CHEMBL1633847,Antimicrobial activity against Staphylococcus haemolyticus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,8.0
54626,,5090880,CHEMBL1633847,Antimicrobial activity against Staphylococcus haemolyticus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.12
54627,,5090884,CHEMBL1633847,Antimicrobial activity against Staphylococcus haemolyticus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,16.0
54628,,5090888,CHEMBL1633844,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.12
54629,,5090893,CHEMBL1633844,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
54630,,5090897,CHEMBL1633844,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,0.25
54631,,5090903,CHEMBL1633841,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,2.0
54632,,5090909,CHEMBL1633841,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,16.0
54633,,5090911,CHEMBL1633841,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
54634,,5090918,CHEMBL1633838,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
54635,,5090923,CHEMBL1633838,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
54636,,5090929,CHEMBL1633838,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
54637,,5090932,CHEMBL1633835,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
54638,,5090936,CHEMBL1633835,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
54639,,5090941,CHEMBL1633835,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
54640,,5090946,CHEMBL1633832,Antimicrobial activity against Moraxella catarrhalis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,0.03
54641,,5090952,CHEMBL1633832,Antimicrobial activity against Moraxella catarrhalis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.06
54642,,5090958,CHEMBL1633832,Antimicrobial activity against Moraxella catarrhalis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.015
54643,,5090961,CHEMBL1633829,Antimicrobial activity against Haemophilus parainfluenzae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614408,Haemophilus parainfluenzae,Haemophilus parainfluenzae,729.0,,MIC90,ug ml-1,UO_0000274,0.06
54644,,5090969,CHEMBL1633829,Antimicrobial activity against Haemophilus parainfluenzae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC50,ug.mL-1,0.015,CHEMBL614408,Haemophilus parainfluenzae,Haemophilus parainfluenzae,729.0,,MIC50,ug ml-1,UO_0000274,0.015
54645,,5090973,CHEMBL1633829,Antimicrobial activity against Haemophilus parainfluenzae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL614408,Haemophilus parainfluenzae,Haemophilus parainfluenzae,729.0,,MIC,ug ml-1,UO_0000274,0.015
54646,,5090984,CHEMBL1633826,Antimicrobial activity against beta-lactamase-negative Haemophilus influenzae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC90,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.015
54647,,5090986,CHEMBL1633826,Antimicrobial activity against beta-lactamase-negative Haemophilus influenzae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC50,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.015
54648,,5090988,CHEMBL1633826,Antimicrobial activity against beta-lactamase-negative Haemophilus influenzae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
54649,,5091000,CHEMBL1633823,Antimicrobial activity against beta-lactamase-producing Haemophilus influenzae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC90,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.015
54650,,5091002,CHEMBL1633823,Antimicrobial activity against beta-lactamase-producing Haemophilus influenzae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC50,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.015
54651,,5091004,CHEMBL1633823,Antimicrobial activity against beta-lactamase-producing Haemophilus influenzae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
54652,,5091009,CHEMBL1633718,Antimicrobial activity against Pseudomonas aeruginosa clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,1.0
54653,,5091012,CHEMBL1633718,Antimicrobial activity against Pseudomonas aeruginosa clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,16.0
54654,,5091018,CHEMBL1633718,Antimicrobial activity against Pseudomonas aeruginosa clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.12
54655,,5091020,CHEMBL1633715,Antimicrobial activity against Stenotrophomonas maltophilia clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,4.0
54656,,5091021,CHEMBL1633715,Antimicrobial activity against Stenotrophomonas maltophilia clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC50,ug ml-1,UO_0000274,1.0
54657,,5091022,CHEMBL1633715,Antimicrobial activity against Stenotrophomonas maltophilia clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.25
54658,,5091036,CHEMBL1633712,Antimicrobial activity against Burkholderia cepacia clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC90,ug ml-1,UO_0000274,4.0
54659,,5091041,CHEMBL1633712,Antimicrobial activity against Burkholderia cepacia clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC50,ug ml-1,UO_0000274,2.0
54660,,5091043,CHEMBL1633712,Antimicrobial activity against Burkholderia cepacia clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,ug ml-1,UO_0000274,0.12
54661,,5091053,CHEMBL1637232,Antimicrobial activity against Acinetobacter lwoffii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC90,ug ml-1,UO_0000274,2.0
54662,,5091755,CHEMBL1637232,Antimicrobial activity against Acinetobacter lwoffii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC50,ug ml-1,UO_0000274,0.12
54663,,5091757,CHEMBL1637232,Antimicrobial activity against Acinetobacter lwoffii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.03
54664,,5091765,CHEMBL1637229,Antimicrobial activity against Acinetobacter junii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,2.0
54665,,5091770,CHEMBL1637229,Antimicrobial activity against Acinetobacter junii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
54666,,5091772,CHEMBL1637229,Antimicrobial activity against Acinetobacter junii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
54667,,5091780,CHEMBL1637226,Antimicrobial activity against Acinetobacter johnsonii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,2.0
54668,,5091785,CHEMBL1637226,Antimicrobial activity against Acinetobacter johnsonii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
54669,,5091787,CHEMBL1637226,Antimicrobial activity against Acinetobacter johnsonii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
54670,,5091795,CHEMBL1637223,Antimicrobial activity against Acinetobacter haemolyticus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL613782,Acinetobacter haemolyticus,Acinetobacter haemolyticus,29430.0,,MIC90,ug ml-1,UO_0000274,2.0
54671,,5091800,CHEMBL1637223,Antimicrobial activity against Acinetobacter haemolyticus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613782,Acinetobacter haemolyticus,Acinetobacter haemolyticus,29430.0,,MIC50,ug ml-1,UO_0000274,0.12
54672,,5091802,CHEMBL1637223,Antimicrobial activity against Acinetobacter haemolyticus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613782,Acinetobacter haemolyticus,Acinetobacter haemolyticus,29430.0,,MIC,ug ml-1,UO_0000274,0.03
54673,,5091808,CHEMBL1637099,Antimicrobial activity against Acinetobacter baumannii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
54674,,5091810,CHEMBL1637099,Antimicrobial activity against Acinetobacter baumannii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,8.0
54675,,5091811,CHEMBL1637099,Antimicrobial activity against Acinetobacter baumannii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
54676,,5091823,CHEMBL1637096,Antimicrobial activity against Acinetobacter calcoaceticus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC90,ug ml-1,UO_0000274,16.0
54677,,5091825,CHEMBL1637096,Antimicrobial activity against Acinetobacter calcoaceticus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC50,ug ml-1,UO_0000274,8.0
54678,,5091826,CHEMBL1637096,Antimicrobial activity against Acinetobacter calcoaceticus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.06
54679,,5091838,CHEMBL1637093,Antimicrobial activity against Providencia stuartii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC90,ug ml-1,UO_0000274,16.0
54680,,5091842,CHEMBL1637093,Antimicrobial activity against Providencia stuartii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC50,ug ml-1,UO_0000274,1.0
54681,,5091850,CHEMBL1637093,Antimicrobial activity against Providencia stuartii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.06,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC,ug ml-1,UO_0000274,0.06
54682,,5091853,CHEMBL1637090,Antimicrobial activity against Providencia rettgeri clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC90,ug ml-1,UO_0000274,16.0
54683,,5091857,CHEMBL1637090,Antimicrobial activity against Providencia rettgeri clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC50,ug ml-1,UO_0000274,1.0
54684,,5091865,CHEMBL1637090,Antimicrobial activity against Providencia rettgeri clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.06,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.06
54685,,5091869,CHEMBL1637087,Antimicrobial activity against Proteus vulgaris clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC90,ug ml-1,UO_0000274,0.12
54686,,5091873,CHEMBL1637087,Antimicrobial activity against Proteus vulgaris clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC50,ug ml-1,UO_0000274,0.03
54687,,5091877,CHEMBL1637087,Antimicrobial activity against Proteus vulgaris clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.03
54688,,5091883,CHEMBL1637084,Antimicrobial activity against Proteus mirabilis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,16.0
54689,,5091886,CHEMBL1637084,Antimicrobial activity against Proteus mirabilis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,0.5
54690,,5091895,CHEMBL1637084,Antimicrobial activity against Proteus mirabilis clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.03
54691,,5091903,CHEMBL1637081,Antimicrobial activity against Morganella morganii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC50,ug ml-1,UO_0000274,0.03
54692,,5091908,CHEMBL1637081,Antimicrobial activity against Morganella morganii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>=,1,1,>=,MIC,ug.mL-1,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.015
54693,,5091909,CHEMBL1637081,Antimicrobial activity against Morganella morganii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,16.0
54694,,5091914,CHEMBL1637078,Antimicrobial activity against Serratia marcescens clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,4.0
54695,,5091918,CHEMBL1637078,Antimicrobial activity against Serratia marcescens clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC50,ug ml-1,UO_0000274,0.12
54696,,5091921,CHEMBL1637078,Antimicrobial activity against Serratia marcescens clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.06
54697,,5091930,CHEMBL1637075,Antimicrobial activity against Klebsiella oxytoca clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC90,ug ml-1,UO_0000274,0.25
54698,,5091935,CHEMBL1637075,Antimicrobial activity against Klebsiella oxytoca clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC50,ug ml-1,UO_0000274,0.03
54699,,5091941,CHEMBL1637075,Antimicrobial activity against Klebsiella oxytoca clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.015
54700,,5091946,CHEMBL1637072,Antimicrobial activity against AmpC- producing Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,2.0
54701,,5091950,CHEMBL1637072,Antimicrobial activity against AmpC- producing Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,16.0
54702,,5091955,CHEMBL1637072,Antimicrobial activity against AmpC- producing Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
54703,,5091959,CHEMBL1637069,Antimicrobial activity against class A extended spectrum beta-lactamase- and class D OXA- producing Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,1.0
54704,,5091963,CHEMBL1637069,Antimicrobial activity against class A extended spectrum beta-lactamase- and class D OXA- producing Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,16.0
54705,,5091970,CHEMBL1637069,Antimicrobial activity against class A extended spectrum beta-lactamase- and class D OXA- producing Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
54706,,5091973,CHEMBL1637066,Antimicrobial activity against class A extended spectrum beta-lactamase- producing Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,8.0
54707,,5091976,CHEMBL1637066,Antimicrobial activity against class A extended spectrum beta-lactamase- producing Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.5
54708,,5091985,CHEMBL1637066,Antimicrobial activity against class A extended spectrum beta-lactamase- producing Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
54709,,5091990,CHEMBL1636082,Antimicrobial activity against Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,0.5
54710,,5091995,CHEMBL1636082,Antimicrobial activity against Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.06
54711,,5091998,CHEMBL1636082,Antimicrobial activity against Klebsiella pneumoniae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
54712,,5092004,CHEMBL1636081,Antimicrobial activity against Citrobacter freundii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,2.0
54713,,5092008,CHEMBL1636081,Antimicrobial activity against Citrobacter freundii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC50,ug ml-1,UO_0000274,0.12
54714,,5092012,CHEMBL1636081,Antimicrobial activity against Citrobacter freundii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>=,1,1,>=,MIC,ug.mL-1,0.015,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.015
54715,,5092020,CHEMBL1636068,Antimicrobial activity against Citrobacter koseri clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,MIC90,ug ml-1,UO_0000274,0.06
54716,,5092024,CHEMBL1636068,Antimicrobial activity against Citrobacter koseri clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,MIC50,ug ml-1,UO_0000274,0.03
54717,,5092031,CHEMBL1636068,Antimicrobial activity against Citrobacter koseri clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,MIC,ug ml-1,UO_0000274,0.015
54718,,5092034,CHEMBL1636080,Antimicrobial activity against Enterobacter aerogenes clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,0.5
54719,,5092039,CHEMBL1636080,Antimicrobial activity against Enterobacter aerogenes clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC50,ug ml-1,UO_0000274,0.06
54720,,5092045,CHEMBL1636080,Antimicrobial activity against Enterobacter aerogenes clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.03
54721,,5092049,CHEMBL1636079,Antimicrobial activity against AmpC beta-lactamase-producing Serratia marcescens clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,8.0
54722,,5092053,CHEMBL1636079,Antimicrobial activity against AmpC beta-lactamase-producing Serratia marcescens clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC50,ug ml-1,UO_0000274,0.12
54723,,5092061,CHEMBL1636079,Antimicrobial activity against AmpC beta-lactamase-producing Serratia marcescens clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.015
54724,,5092064,CHEMBL1636078,Antimicrobial activity against AmpC beta-lactamase-producing Enterobacter cloacae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,8.0
54725,,5092068,CHEMBL1636078,Antimicrobial activity against AmpC beta-lactamase-producing Enterobacter cloacae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,0.12
54726,,5092076,CHEMBL1636078,Antimicrobial activity against AmpC beta-lactamase-producing Enterobacter cloacae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.015
54727,,5092079,CHEMBL1636077,Antimicrobial activity against AmpC beta-lactamase-producing Enterobacter aerogenes clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,8.0
54728,,5092083,CHEMBL1636077,Antimicrobial activity against AmpC beta-lactamase-producing Enterobacter aerogenes clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC50,ug ml-1,UO_0000274,0.12
54729,,5092751,CHEMBL1636077,Antimicrobial activity against AmpC beta-lactamase-producing Enterobacter aerogenes clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.015
54730,,5092754,CHEMBL1636076,Antimicrobial activity against AmpC beta-lactamase-producing Citrobacter freundii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,8.0
54731,,5092758,CHEMBL1636076,Antimicrobial activity against AmpC beta-lactamase-producing Citrobacter freundii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC50,ug ml-1,UO_0000274,0.12
54732,,5092766,CHEMBL1636076,Antimicrobial activity against AmpC beta-lactamase-producing Citrobacter freundii clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.015
54733,,5092769,CHEMBL1636075,Antimicrobial activity against AmpC beta-lactamase-producing Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
54734,,5092773,CHEMBL1636075,Antimicrobial activity against AmpC beta-lactamase-producing Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
54735,,5092780,CHEMBL1636075,Antimicrobial activity against AmpC beta-lactamase-producing Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54736,,5092784,CHEMBL1636074,Antimicrobial activity against class A extended spectrum beta-lactamase- producing Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,8.0
54737,,5092787,CHEMBL1636074,Antimicrobial activity against class A extended spectrum beta-lactamase- producing Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>=,1,1,>=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
54738,,5092790,CHEMBL1636074,Antimicrobial activity against class A extended spectrum beta-lactamase- producing Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
54739,,5092799,CHEMBL1636072,Antimicrobial activity against class A extended spectrum beta-lactamase- and class D OXA- producing Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,16.0
54740,,5092803,CHEMBL1636072,Antimicrobial activity against class A extended spectrum beta-lactamase- and class D OXA- producing Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
54741,,5092810,CHEMBL1636072,Antimicrobial activity against class A extended spectrum beta-lactamase- and class D OXA- producing Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
54742,,5092815,CHEMBL1636073,Antimicrobial activity against Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,8.0
54743,,5092819,CHEMBL1636073,Antimicrobial activity against Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.03
54744,,5092823,CHEMBL1636073,Antimicrobial activity against Escherichia coli clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>=,1,1,>=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
54745,,5092831,CHEMBL1634703,Antimicrobial activity against Streptococcus pyogenes clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.5
54746,,5092835,CHEMBL1634703,Antimicrobial activity against Streptococcus pyogenes clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.12
54747,,5092839,CHEMBL1634703,Antimicrobial activity against Streptococcus pyogenes clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
54748,,5092843,CHEMBL1634978,Antimicrobial activity against Streptococcus agalactiae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
54749,,5092848,CHEMBL1634978,Antimicrobial activity against Streptococcus agalactiae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
54750,,5092853,CHEMBL1634978,Antimicrobial activity against Streptococcus agalactiae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,1.0
54751,,5092912,CHEMBL1634827,Antimicrobial activity against Enterococcus casseliflavus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL4523080,Enterococcus casseliflavus,Enterococcus casseliflavus,37734.0,,MIC90,ug ml-1,UO_0000274,8.0
54752,,5092916,CHEMBL1634827,Antimicrobial activity against Enterococcus casseliflavus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL4523080,Enterococcus casseliflavus,Enterococcus casseliflavus,37734.0,,MIC,ug ml-1,UO_0000274,0.25
54753,,5092923,CHEMBL1634827,Antimicrobial activity against Enterococcus casseliflavus clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL4523080,Enterococcus casseliflavus,Enterococcus casseliflavus,37734.0,,MIC50,ug ml-1,UO_0000274,1.0
54754,,5092927,CHEMBL1634830,Antimicrobial activity against Enterococcus durans clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612292,Enterococcus durans,Enterococcus durans,53345.0,,MIC90,ug ml-1,UO_0000274,8.0
54755,,5092931,CHEMBL1634830,Antimicrobial activity against Enterococcus durans clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL612292,Enterococcus durans,Enterococcus durans,53345.0,,MIC,ug ml-1,UO_0000274,0.25
54756,,5092938,CHEMBL1634830,Antimicrobial activity against Enterococcus durans clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612292,Enterococcus durans,Enterococcus durans,53345.0,,MIC50,ug ml-1,UO_0000274,1.0
54757,,5092942,CHEMBL1634833,Antimicrobial activity against Enterococcus gallinarum clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL613817,Enterococcus gallinarum,Enterococcus gallinarum,1353.0,,MIC90,ug ml-1,UO_0000274,8.0
54758,,5092946,CHEMBL1634833,Antimicrobial activity against Enterococcus gallinarum clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL613817,Enterococcus gallinarum,Enterococcus gallinarum,1353.0,,MIC,ug ml-1,UO_0000274,0.25
54759,,5092953,CHEMBL1634833,Antimicrobial activity against Enterococcus gallinarum clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL613817,Enterococcus gallinarum,Enterococcus gallinarum,1353.0,,MIC50,ug ml-1,UO_0000274,1.0
54760,,5092957,CHEMBL1634836,Antimicrobial activity against Enterococcus hirae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MIC90,ug ml-1,UO_0000274,8.0
54761,,5092961,CHEMBL1634836,Antimicrobial activity against Enterococcus hirae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MIC,ug ml-1,UO_0000274,0.25
54762,,5092968,CHEMBL1634836,Antimicrobial activity against Enterococcus hirae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MIC50,ug ml-1,UO_0000274,1.0
54763,,5092974,CHEMBL1636070,Antimicrobial activity against Enterobacter cloacae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,16.0
54764,,5092977,CHEMBL1636070,Antimicrobial activity against Enterobacter cloacae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,>=,1,1,>=,MIC,ug.mL-1,0.015,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.015
54765,,5092982,CHEMBL1636070,Antimicrobial activity against Enterobacter cloacae clinical isolate after 18 to 22 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629583,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314346,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,0.06
54766,,5093290,CHEMBL1638018,Antimicrobial activity against Acinetobacter baumannii VT 126 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315315,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug/L,UO_0000274,8.0
54767,,5093291,CHEMBL1638019,Antimicrobial activity against Haemophilus influenzae VT450-2006 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315315,=,1,1,=,MIC,ug.mL-1,7e-05,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug/L,UO_0000274,0.07
54768,,5093292,CHEMBL1638020,Antimicrobial activity against Klebsiella pneumoniae VT 1367 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315315,=,1,1,=,MIC,ug.mL-1,0.00015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug/L,UO_0000274,0.15
54769,,5093293,CHEMBL1638021,Antimicrobial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315315,=,1,1,=,MIC,ug.mL-1,3.5e-05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug/L,UO_0000274,0.035
54770,,5093294,CHEMBL1638022,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315315,=,1,1,=,MIC,ug.mL-1,0.0006,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug/L,UO_0000274,0.6
54771,,5093295,CHEMBL1638023,Antimicrobial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315315,=,1,1,=,MIC,ug.mL-1,0.0003,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,0.3
54772,,5093296,CHEMBL1638024,Antimicrobial activity against Streptococcus pyogenes VT 59 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315315,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug/L,UO_0000274,0.5
54773,,5093325,CHEMBL1638032,Bactericidal activity against Acinetobacter baumannii VT 126 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs by serial dilution,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315315,=,1,0,=,log10cfu,,8.26,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,log10cfu,,,8.26
54774,,5093326,CHEMBL1638033,Bactericidal activity against Haemophilus influenzae VT450-2006 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs by serial dilution,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315315,=,1,0,=,log10cfu,,8.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,log10cfu,,,8.25
54775,,5093327,CHEMBL1638034,Bactericidal activity against Klebsiella pneumoniae VT 1367 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs by serial dilution,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315315,=,1,0,=,log10cfu,,8.62,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,log10cfu,,,8.62
54776,,5093328,CHEMBL1638035,Bactericidal activity against Escherichia coli ATCC 25922 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs by serial dilution,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315315,=,1,0,=,log10cfu,,8.46,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,log10cfu,,,8.46
54777,,5093329,CHEMBL1638036,Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs by serial dilution,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315315,=,1,0,=,log10cfu,,8.69,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,log10cfu,,,8.69
54778,,5093330,CHEMBL1638037,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs by serial dilution,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315315,=,1,0,=,log10cfu,,7.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,7.39
54779,,5093331,CHEMBL1638038,Bactericidal activity against Streptococcus pyogenes VT 59 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs by serial dilution,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315315,=,1,0,=,log10cfu,,6.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,log10cfu,,,6.39
54780,Not Active,5093360,CHEMBL1638025,Bactericidal activity against Acinetobacter baumannii VT 126 assessed as eradication of pre-formed biofilm at 1 to 10 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,,1,0,,Inhibition,%,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,INH,,UO_0000187,
54781,Not Active,5093361,CHEMBL1638026,Bactericidal activity against Haemophilus influenzae VT450-2006 assessed as eradication of pre-formed biofilm at 1 to 10 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,,1,0,,Inhibition,%,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,INH,,UO_0000187,
54782,Not Active,5093362,CHEMBL1638027,Bactericidal activity against Klebsiella pneumoniae VT 1367 assessed as eradication of pre-formed biofilm at 1 to 10 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,,1,0,,Inhibition,%,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,INH,,UO_0000187,
54783,Not Active,5093363,CHEMBL1638028,Bactericidal activity against Escherichia coli ATCC 25922 assessed as eradication of pre-formed biofilm at 1 to 10 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,,1,0,,Inhibition,%,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,,UO_0000187,
54784,Not Active,5093364,CHEMBL1638029,Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 assessed as eradication of pre-formed biofilm at 1 to 10 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
54785,Not Active,5093365,CHEMBL1638030,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as eradication of pre-formed biofilm at 1 to 10 times MIC after 24 hrs by serial dilution,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,,1,0,,Inhibition,%,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,,UO_0000187,
54786,Not Active,5093366,CHEMBL1638031,Bactericidal activity against Streptococcus pyogenes VT 59 assessed as eradication of pre-formed biofilm at 1 to 10 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,,1,0,,Inhibition,%,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,INH,,UO_0000187,
54787,,5093377,CHEMBL1638039,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,=,1,1,=,Inhibition,%,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,%,UO_0000187,10.0
54788,,5093378,CHEMBL1638040,Bactericidal activity against Streptococcus pyogenes VT 59 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,=,1,1,=,Inhibition,%,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,INH,%,UO_0000187,10.0
54789,,5093379,CHEMBL1638041,Bactericidal activity against Acinetobacter baumannii VT 126 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,=,1,1,=,Inhibition,%,10.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,INH,%,UO_0000187,10.0
54790,,5093380,CHEMBL1638042,Bactericidal activity against Haemophilus influenzae VT450-2006 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,=,1,1,=,Inhibition,%,10.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,INH,%,UO_0000187,10.0
54791,,5093381,CHEMBL1638043,Bactericidal activity against Klebsiella pneumoniae VT 1367 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,=,1,1,=,Inhibition,%,10.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,INH,%,UO_0000187,10.0
54792,,5093382,CHEMBL1638044,Bactericidal activity against Escherichia coli ATCC 25922 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,=,1,1,=,Inhibition,%,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,%,UO_0000187,10.0
54793,,5093383,CHEMBL1638045,Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 assessed as eradication of pre-formed biofilm at 50 times MIC after 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629635,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315315,=,1,1,=,Inhibition,%,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,10.0
54794,,5096364,CHEMBL1634968,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629645,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315505,=,1,1,=,MIC,ug.mL-1,0.16,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.16
54795,,5096365,CHEMBL1634967,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 during logarithmic growth phase by macrodilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629645,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315505,=,1,0,=,MBC,ug ml-1,0.63,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.63
54796,,5096366,CHEMBL1634966,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 during stationary growth phase by macrodilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629645,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315505,>,1,0,>,MBC,ug ml-1,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,20.0
54797,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5096376,CHEMBL1634954,"Cmax in cage fluid of Albino guiena pig at 10 mg/kg, ip after 12 hrs",A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629645,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,1315505,=,1,1,=,Cmax,nM,4150.87,CHEMBL612558,,ADMET,,,Cmax,ug ml-1,UO_0000065,1.5
54798,,5096396,CHEMBL1634934,"AUC (0 to 24 hrs) in cage fluid of Albino guiena pig at 10 mg/kg, ip",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629645,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315505,=,1,1,=,AUC,ng.hr.mL-1,6100.0,CHEMBL612558,,ADMET,,,AUC,ug.hr/ml,,6.1
54799,,5096401,CHEMBL1634930,"Ratio of Cmax to MIC for methicillin-resistant Staphylococcus aureus ATCC 43300 in Albino guiena pig model of foreign-body infection at 10 mg/kg, ip",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629645,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315505,=,1,0,=,Ratio,,9.4,CHEMBL612545,,Unchecked,,,Ratio,,,9.4
54800,,5096406,CHEMBL1634925,"Ratio of AUC (0 to 24 hrs) to MIC for methicillin-resistant Staphylococcus aureus ATCC 43300 in Albino guiena pig model of foreign-body infection at 10 mg/kg, ip",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629645,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1315505,=,1,0,=,Ratio,,38.1,CHEMBL612545,,Unchecked,,,Ratio,,,38.1
54801,,5096852,CHEMBL1636920,Antibacterial activity against Streptococcus pneumoniae U2A1060 harboring gyrA Ser81Phe parC Asp83His mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
54802,,5096853,CHEMBL1636917,Antibacterial activity against Streptococcus pneumoniae U2A1681 harboring parC Ser79Tyr Asp83Ala mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
54803,,5096866,CHEMBL1636739,Antibacterial activity against Streptococcus pneumoniae U2A1686 harboring gyrA Glu85Lys mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,26.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,26.0
54804,,5096878,CHEMBL1636737,Antibacterial activity against Streptococcus pneumoniae CP1000 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,24.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,24.0
54805,,5096884,CHEMBL1636738,Antibacterial activity against Streptococcus pneumoniae R6 Tr6 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,23.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,23.0
54806,,5096891,CHEMBL1636746,Antibacterial activity against Streptococcus pneumoniae U2A1413 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,22.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,22.0
54807,,5096892,CHEMBL1636745,Antibacterial activity against Streptococcus pneumoniae U2A1053 harboring parC Ser79Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,22.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,22.0
54808,,5096893,CHEMBL1636741,Antibacterial activity against Streptococcus pneumoniae U2A1051 harboring gyrA Ser81Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,22.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,22.0
54809,,5096894,CHEMBL1636735,Antibacterial activity against Streptococcus pneumoniae CIP104485 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,22.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,22.0
54810,,5096900,CHEMBL1636744,Antibacterial activity against Streptococcus pneumoniae R6 Tr1 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,21.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,21.0
54811,,5096901,CHEMBL1636742,Antibacterial activity against Streptococcus pneumoniae U2A1266 harboring gyrA Ser81Cys mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,21.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,21.0
54812,,5096902,CHEMBL1636736,Antibacterial activity against Streptococcus pneumoniae R6 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,21.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,21.0
54813,,5096911,CHEMBL1636747,Antibacterial activity against Streptococcus pneumoniae U2A1693 harboring parC Asp83Asn mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,19.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,19.0
54814,,5096912,CHEMBL1636740,Antibacterial activity against Streptococcus pneumoniae U2A1050 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,19.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,19.0
54815,,5096930,CHEMBL1636918,Antibacterial activity against Streptococcus pneumoniae R6 Tr10 harboring gyrA Ser81Tyr parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
54816,,5096931,CHEMBL1636911,Antibacterial activity against Streptococcus pneumoniae H548 clinical isolate harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
54817,,5096932,CHEMBL1636748,Antibacterial activity against Streptococcus pneumoniae U2A1411 harboring parC Asp83Gly mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,15.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,15.0
54818,,5096942,CHEMBL1636900,Antibacterial activity against Streptococcus pneumoniae U2A1056 harboring gyrA Ser81Tyr parC Asp83His mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,1312954,=,1,1,=,IZ,mm,12.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,12.0
54819,,5096957,CHEMBL1636919,Antibacterial activity against Streptococcus pneumoniae U2A1056 harboring gyrA Ser81Tyr parC Asp83His mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312954,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
54820,,5097421,CHEMBL1637974,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
54821,,5097422,CHEMBL1637975,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
54822,,5097423,CHEMBL1637976,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
54823,,5097424,CHEMBL1637977,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
54824,,5097425,CHEMBL1637978,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.12
54825,,5097426,CHEMBL1637979,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.06
54826,,5097427,CHEMBL1637980,Antimicrobial activity against Enterococcus faecalis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
54827,,5097428,CHEMBL1637981,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
54828,,5097429,CHEMBL1637982,Antimicrobial activity against Enterococcus faecium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,1.0
54829,,5097430,CHEMBL1637983,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.5
54830,,5097431,CHEMBL1637984,Antimicrobial activity against Corynebacterium jeikeium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,MIC,ug ml-1,UO_0000274,0.5
54831,,5097432,CHEMBL1637985,Antimicrobial activity against Listeria monocytogenes by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,1.0
54832,,5097433,CHEMBL1637986,Antimicrobial activity against Streptococcus agalactiae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
54833,,5097434,CHEMBL1637987,Antimicrobial activity against levofloxacin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
54834,,5097435,CHEMBL1637988,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
54835,,5097436,CHEMBL1637989,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
54836,,5097437,CHEMBL1637990,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
54837,,5097438,CHEMBL1637991,Antimicrobial activity against macrolide-resistant Streptococcus pyogenes by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
54838,,5097439,CHEMBL1637992,Antimicrobial activity against macrolide-susceptible Streptococcus pyogenes by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
54839,,5097440,CHEMBL1637993,Antimicrobial activity against Streptococcus viridans group clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,0.12
54840,,5097441,CHEMBL1637994,Antimicrobial activity against ESBL-negative Enterobacter aerogenes by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.03
54841,,5097442,CHEMBL1637995,Antimicrobial activity against ESBL-negative Enterobacter cloacae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.015
54842,,5097443,CHEMBL1637996,Antimicrobial activity against ESBL-negative Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
54843,,5097444,CHEMBL1637997,Antimicrobial activity against ESBL-positive Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
54844,,5097445,CHEMBL1637998,Antimicrobial activity against ESBL-negative Klebsiella pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.015
54845,,5097446,CHEMBL1637999,Antimicrobial activity against ESBL-positive Klebsiella pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
54846,,5097447,CHEMBL1638000,Antimicrobial activity against Morganella morganii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.015
54847,,5097448,CHEMBL1638001,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.03
54848,,5097449,CHEMBL1638002,Antimicrobial activity against Proteus rettgeri by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.06
54849,,5097450,CHEMBL1636122,Antimicrobial activity against Proteus stuartii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC,ug ml-1,UO_0000274,0.06
54850,,5097451,CHEMBL1636123,Antimicrobial activity against Proteus vulgaris by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.015
54851,,5097452,CHEMBL1636124,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.06
54852,,5097453,CHEMBL1636125,Antimicrobial activity against Shigella spp. by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614397,Shigella sp.,Shigella sp.,625.0,,MIC,ug ml-1,UO_0000274,0.015
54853,,5097454,CHEMBL1636126,Antimicrobial activity against Salmonella spp. by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612618,Salmonella sp.,Salmonella sp.,599.0,,MIC,ug ml-1,UO_0000274,0.03
54854,,5097455,CHEMBL1636127,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,ug ml-1,UO_0000274,0.015
54855,,5097456,CHEMBL1636128,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
54856,,5097457,CHEMBL1636129,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
54857,,5097458,CHEMBL1636130,Antimicrobial activity against Stenotrophomonas maltophilia by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.06
54858,,5097459,CHEMBL1636131,Antimicrobial activity against Moraxella catarrhalis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.015
54859,,5097460,CHEMBL1636132,Antimicrobial activity against beta-lactamase-negative Haemophilus influenzae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
54860,,5097461,CHEMBL1636133,Antimicrobial activity against beta-lactamase-positive Haemophilus influenzae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
54861,,5097462,CHEMBL1636134,Antimicrobial activity against beta-lactamase-negative ampicillin resistant Haemophilus influenzae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
54862,,5097587,CHEMBL1637974,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
54863,,5097588,CHEMBL1637975,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
54864,,5097589,CHEMBL1637976,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,16.0
54865,,5097590,CHEMBL1637978,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,8.0
54866,,5097591,CHEMBL1637979,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.25
54867,,5097592,CHEMBL1637980,Antimicrobial activity against Enterococcus faecalis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
54868,,5097593,CHEMBL1637981,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
54869,,5097594,CHEMBL1637982,Antimicrobial activity against Enterococcus faecium by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC50,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,32.0
54870,,5097595,CHEMBL1637983,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,2.0
54871,,5097596,CHEMBL1637984,Antimicrobial activity against Corynebacterium jeikeium by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC50,ug.mL-1,32.0,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,MIC50,ug ml-1,UO_0000274,32.0
54872,,5097597,CHEMBL1637985,Antimicrobial activity against Listeria monocytogenes by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC50,ug ml-1,UO_0000274,1.0
54873,,5097598,CHEMBL1637986,Antimicrobial activity against Streptococcus agalactiae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,1.0
54874,,5097599,CHEMBL1637987,Antimicrobial activity against levofloxacin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,16.0
54875,,5097600,CHEMBL1637988,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54876,,5097601,CHEMBL1637989,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54877,,5097602,CHEMBL1637990,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
54878,,5097603,CHEMBL1637991,Antimicrobial activity against macrolide-resistant Streptococcus pyogenes by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
54879,,5097604,CHEMBL1637992,Antimicrobial activity against macrolide-susceptible Streptococcus pyogenes by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
54880,,5097605,CHEMBL1637993,Antimicrobial activity against Streptococcus viridans group clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC50,ug ml-1,UO_0000274,1.0
54881,,5097606,CHEMBL1637994,Antimicrobial activity against ESBL-negative Enterobacter aerogenes by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC50,ug ml-1,UO_0000274,0.06
54882,,5097607,CHEMBL1637995,Antimicrobial activity against ESBL-negative Enterobacter cloacae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,0.03
54883,,5097608,CHEMBL1637996,Antimicrobial activity against ESBL-negative Escherichia coli by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.03
54884,,5097609,CHEMBL1637997,Antimicrobial activity against ESBL-positive Escherichia coli by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.25
54885,,5097610,CHEMBL1637998,Antimicrobial activity against ESBL-negative Klebsiella pneumoniae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.06
54886,,5097611,CHEMBL1637999,Antimicrobial activity against ESBL-positive Klebsiella pneumoniae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.5
54887,,5097612,CHEMBL1638000,Antimicrobial activity against Morganella morganii by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC50,ug ml-1,UO_0000274,0.06
54888,,5097613,CHEMBL1638001,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,0.03
54889,,5097614,CHEMBL1638002,Antimicrobial activity against Proteus rettgeri by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC50,ug ml-1,UO_0000274,0.12
54890,,5097615,CHEMBL1636122,Antimicrobial activity against Proteus stuartii by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC50,ug ml-1,UO_0000274,0.12
54891,,5097616,CHEMBL1636123,Antimicrobial activity against Proteus vulgaris by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC50,ug ml-1,UO_0000274,0.03
54892,,5097617,CHEMBL1636124,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC50,ug ml-1,UO_0000274,0.12
54893,,5097618,CHEMBL1636125,Antimicrobial activity against Shigella spp. by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614397,Shigella sp.,Shigella sp.,625.0,,MIC50,ug ml-1,UO_0000274,0.03
54894,,5097619,CHEMBL1636126,Antimicrobial activity against Salmonella spp. by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL612618,Salmonella sp.,Salmonella sp.,599.0,,MIC50,ug ml-1,UO_0000274,0.03
54895,,5097620,CHEMBL1636127,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC50,ug ml-1,UO_0000274,1.0
54896,,5097621,CHEMBL1636128,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,2.0
54897,,5097622,CHEMBL1636129,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,32.0
54898,,5097623,CHEMBL1636130,Antimicrobial activity against Stenotrophomonas maltophilia by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC50,ug ml-1,UO_0000274,1.0
54899,,5097624,CHEMBL1636131,Antimicrobial activity against Moraxella catarrhalis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,0.03
54900,,5097625,CHEMBL1636132,Antimicrobial activity against beta-lactamase-negative Haemophilus influenzae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.03
54901,,5097626,CHEMBL1636133,Antimicrobial activity against beta-lactamase-positive Haemophilus influenzae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.03
54902,,5097627,CHEMBL1636134,Antimicrobial activity against beta-lactamase-negative ampicillin resistant Haemophilus influenzae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.03
54903,,5098093,CHEMBL1637974,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,32.0
54904,,5098094,CHEMBL1637975,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
54905,,5098095,CHEMBL1637976,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,32.0
54906,,5098096,CHEMBL1637978,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,32.0
54907,,5098097,CHEMBL1637979,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,16.0
54908,,5098098,CHEMBL1637980,Antimicrobial activity against Enterococcus faecalis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,32.0
54909,,5098099,CHEMBL1637981,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,32.0
54910,,5098100,CHEMBL1637982,Antimicrobial activity against Enterococcus faecium by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,32.0
54911,,5098101,CHEMBL1637983,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,32.0
54912,,5098102,CHEMBL1637984,Antimicrobial activity against Corynebacterium jeikeium by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,MIC90,ug ml-1,UO_0000274,32.0
54913,,5098103,CHEMBL1637985,Antimicrobial activity against Listeria monocytogenes by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC90,ug ml-1,UO_0000274,1.0
54914,,5098104,CHEMBL1637986,Antimicrobial activity against Streptococcus agalactiae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
54915,,5098105,CHEMBL1637987,Antimicrobial activity against levofloxacin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,32.0
54916,,5098106,CHEMBL1637988,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54917,,5098107,CHEMBL1637989,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
54918,,5098108,CHEMBL1637990,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
54919,,5098109,CHEMBL1637991,Antimicrobial activity against macrolide-resistant Streptococcus pyogenes by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.5
54920,,5098110,CHEMBL1637992,Antimicrobial activity against macrolide-susceptible Streptococcus pyogenes by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,2.0
54921,,5098111,CHEMBL1637993,Antimicrobial activity against Streptococcus viridans group clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC90,ug ml-1,UO_0000274,2.0
54922,,5098112,CHEMBL1637994,Antimicrobial activity against ESBL-negative Enterobacter aerogenes by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,0.5
54923,,5098113,CHEMBL1637995,Antimicrobial activity against ESBL-negative Enterobacter cloacae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,0.06
54924,,5098114,CHEMBL1637996,Antimicrobial activity against ESBL-negative Escherichia coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,0.25
54925,,5098115,CHEMBL1637997,Antimicrobial activity against ESBL-positive Escherichia coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
54926,,5098116,CHEMBL1637998,Antimicrobial activity against ESBL-negative Klebsiella pneumoniae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,0.5
54927,,5098117,CHEMBL1637999,Antimicrobial activity against ESBL-positive Klebsiella pneumoniae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,8.0
54928,,5098118,CHEMBL1638000,Antimicrobial activity against Morganella morganii by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,8.0
54929,,5098119,CHEMBL1638001,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,0.25
54930,,5098120,CHEMBL1638002,Antimicrobial activity against Proteus rettgeri by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC90,ug ml-1,UO_0000274,32.0
54931,,5098121,CHEMBL1636122,Antimicrobial activity against Proteus stuartii by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC90,ug ml-1,UO_0000274,32.0
54932,,5098122,CHEMBL1636123,Antimicrobial activity against Proteus vulgaris by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC90,ug ml-1,UO_0000274,0.06
54933,,5098123,CHEMBL1636124,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,0.25
54934,,5098124,CHEMBL1636125,Antimicrobial activity against Shigella spp. by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614397,Shigella sp.,Shigella sp.,625.0,,MIC90,ug ml-1,UO_0000274,0.06
54935,,5098125,CHEMBL1636126,Antimicrobial activity against Salmonella spp. by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL612618,Salmonella sp.,Salmonella sp.,599.0,,MIC90,ug ml-1,UO_0000274,0.06
54936,,5098126,CHEMBL1636127,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC90,ug ml-1,UO_0000274,32.0
54937,,5098127,CHEMBL1636128,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,32.0
54938,,5098128,CHEMBL1636129,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,32.0
54939,,5098129,CHEMBL1636130,Antimicrobial activity against Stenotrophomonas maltophilia by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,16.0
54940,,5098130,CHEMBL1636131,Antimicrobial activity against Moraxella catarrhalis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.03
54941,,5098131,CHEMBL1636132,Antimicrobial activity against beta-lactamase-negative Haemophilus influenzae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.03
54942,,5098132,CHEMBL1636133,Antimicrobial activity against beta-lactamase-positive Haemophilus influenzae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.03
54943,,5098133,CHEMBL1636134,Antimicrobial activity against beta-lactamase-negative ampicillin resistant Haemophilus influenzae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313002,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.06
54944,,5105285,CHEMBL1638992,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54945,,5105286,CHEMBL1638993,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54946,,5105287,CHEMBL1638994,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54947,,5105288,CHEMBL1638995,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54948,,5105289,CHEMBL1638996,"Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 24 hrs by Etest",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54949,,5105290,CHEMBL1639733,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54950,,5105291,CHEMBL1639734,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54951,,5105292,CHEMBL1639735,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54952,,5105293,CHEMBL1639736,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54953,,5105294,CHEMBL1639737,"Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 48 hrs by Etest",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313070,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
54954,,5105375,CHEMBL1639951,Antimicrobial activity against Beta-hemolytic Streptococcus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC90,ug ml-1,UO_0000274,1.0
54955,,5105383,CHEMBL1639951,Antimicrobial activity against Beta-hemolytic Streptococcus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC50,ug ml-1,UO_0000274,0.5
54956,,5106506,CHEMBL1641024,Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus assessed as percent resistant isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,61.4,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,Activity,%,UO_0000187,61.4
54957,,5106512,CHEMBL1641023,Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus assessed as percent resistant isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,11.1,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,Activity,%,UO_0000187,11.1
54958,,5106519,CHEMBL1639942,Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus assessed as percent resistant isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,80.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,80.1
54959,,5106525,CHEMBL1639940,Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,6.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,6.7
54960,,5106532,CHEMBL1640810,Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,31.8,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,Activity,%,UO_0000187,31.8
54961,,5106540,CHEMBL1640809,Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,87.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,Activity,%,UO_0000187,87.5
54962,,5106548,CHEMBL1640808,Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,18.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,18.3
54963,,5106556,CHEMBL1640807,Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,92.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,92.8
54964,,5106564,CHEMBL1639946,Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.5
54965,,5106572,CHEMBL1639946,Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,4.0
54966,,5106580,CHEMBL1639946,Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,4.0
54967,,5106588,CHEMBL1639945,Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.5
54968,,5106596,CHEMBL1639945,Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,4.0
54969,,5106604,CHEMBL1639945,Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.5
54970,,5106612,CHEMBL1639944,Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
54971,,5106620,CHEMBL1639944,Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,4.0
54972,,5106628,CHEMBL1639944,Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
54973,,5106636,CHEMBL1639943,Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
54974,,5106644,CHEMBL1639943,Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
54975,,5106652,CHEMBL1639943,Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
54976,,5106708,CHEMBL1639951,Antimicrobial activity against Beta-hemolytic Streptococcus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC,ug ml-1,UO_0000274,0.5
54977,,5106716,CHEMBL1639952,Antimicrobial activity against viridans group Streptococcus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC50,ug ml-1,UO_0000274,1.0
54978,,5106724,CHEMBL1639952,Antimicrobial activity against viridans group Streptococcus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC90,ug ml-1,UO_0000274,2.0
54979,,5106732,CHEMBL1639952,Antimicrobial activity against viridans group Streptococcus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313933,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC,ug ml-1,UO_0000274,0.5
54980,,5106740,CHEMBL1640815,Antimicrobial activity against Beta-hemolytic Streptococcus assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,98.6,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,98.6
54981,,5106748,CHEMBL1640816,Antimicrobial activity against viridans group Streptococcus assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,95.7,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,95.7
54982,,5106753,CHEMBL1639037,Antimicrobial activity against Beta-hemolytic Streptococcus assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,8.2,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,8.2
54983,,5106757,CHEMBL1639038,Antimicrobial activity against viridans group Streptococcus assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1313933,=,1,0,=,Activity,%,3.6,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,3.6
54984,,5118051,CHEMBL1636261,Antimicrobial activity against Citrobacter freundii obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,78.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,78.0
54985,,5118052,CHEMBL1636264,Antimicrobial activity against Enterobacter aerogenes obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,96.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,Activity,%,UO_0000187,96.0
54986,,5118053,CHEMBL1636267,Antimicrobial activity against Enterobacter cloacae obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,88.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,88.0
54987,,5118054,CHEMBL1636270,Antimicrobial activity against Escherichia coli obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,81.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,81.0
54988,,5118055,CHEMBL1636273,Antimicrobial activity against extended-spectrum beta-lactamase-positive Escherichia coli obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,33.0
54989,,5118056,CHEMBL1636276,Antimicrobial activity against extended-spectrum beta-lactamase-negative Escherichia coli obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,83.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,83.0
54990,,5118057,CHEMBL1636424,Antimicrobial activity against Klebsiella pneumoniae assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,84.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,84.0
54991,,5118058,CHEMBL1636427,Antimicrobial activity against extended-spectrum beta-lactamase-positive Klebsiella pneumoniae assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,28.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,28.0
54992,,5118059,CHEMBL1636430,Antimicrobial activity against extended-spectrum beta-lactamase-negative Klebsiella pneumoniae assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,96.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,96.0
54993,,5118060,CHEMBL1636433,Antimicrobial activity against extended-spectrum beta-lactamase-positive Klebsiella oxytoca assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,100.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,100.0
54994,,5118061,CHEMBL1636436,Antimicrobial activity against extended-spectrum beta-lactamase-positive Proteus mirabilis assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,100.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,100.0
54995,,5118062,CHEMBL1636439,Antimicrobial activity against Pseudomonas aeruginosa assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,72.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,72.0
54996,,5118063,CHEMBL1636442,Antimicrobial activity against Serratia marcescens assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,93.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,%,UO_0000187,93.0
54997,,5118064,CHEMBL1636445,Antimicrobial activity against Pasteurella sp. assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,47.0,CHEMBL614605,Pasteurella sp.,Pasteurella sp.,759.0,,Activity,%,UO_0000187,47.0
54998,,5118065,CHEMBL1636448,Antimicrobial activity against Pseudomonas fluorescens assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,47.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,Activity,%,UO_0000187,47.0
54999,,5118066,CHEMBL1637282,Antimicrobial activity against Stenotrophomonas maltophilia assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,47.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,47.0
